<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Clin Exp Gastroenterol</journal-id>
<journal-id journal-id-type="iso-abbrev">Clin Exp Gastroenterol</journal-id>
<journal-id journal-id-type="publisher-id">Clinical and Experimental Gastroenterology</journal-id>
<journal-title-group>
<journal-title>Clinical and Experimental Gastroenterology</journal-title>
</journal-title-group>
<issn pub-type="epub">1178-7023</issn>
<publisher>
<publisher-name>Dove Medical Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28503071</article-id>
<article-id pub-id-type="pmc">5426469</article-id>
<article-id pub-id-type="doi">10.2147/CEG.S126243</article-id>
<article-id pub-id-type="publisher-id">ceg-10-091</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The ecological community of commensal, symbiotic, and pathogenic gastrointestinal microorganisms – an appraisal</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Haque</surname>
<given-names>Seraj Zohurul</given-names>
</name>
<xref ref-type="aff" rid="af1-ceg-10-091">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Haque</surname>
<given-names>Mainul</given-names>
</name>
<xref ref-type="aff" rid="af2-ceg-10-091">2</xref>
<xref ref-type="corresp" rid="c1-ceg-10-091"></xref>
</contrib>
</contrib-group>
<aff id="af1-ceg-10-091"><label>1</label>School of Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, Scotland, UK</aff>
<aff id="af2-ceg-10-091"><label>2</label>Unit of Pharmacology, Faculty of Medicine and Defense Health, National Defense University of Malaysia, Kem Sungai Besi, Kuala Lumpur, Malaysia</aff>
<author-notes>
<corresp id="c1-ceg-10-091">Correspondence: Mainul Haque, Unit of Pharmacology, Faculty of Medicine and Defense Health, National Defense University of Malaysia, Kem Sungai Besi, 57000 Kuala Lumpur, Malaysia, Tel +60 1 0926 5543, Email <email>runurono@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>05</day>
<month>5</month>
<year>2017</year>
</pub-date>
<volume>10</volume>
<fpage>91</fpage>
<lpage>103</lpage>
<permissions>
<copyright-statement>© 2017 Haque and Haque. This work is published and licensed by Dove Medical Press Limited</copyright-statement>
<copyright-year>2017</copyright-year>
<license>
<license-p>The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p>
</license>
</permissions>
<abstract>
<p>The human gastrointestinal tract is inhabited by a vast population of bacteria, numbering ~100 trillion. These microorganisms have been shown to play a significant role in digestion, metabolism, and the immune system. The aim of this study was to review and discuss how the human body interacts with its gut microbiome and in turn the effects that the microorganisms have on its host, overall resulting in a true mutualistic relationship.</p>
</abstract>
<abstract abstract-type="graphical">
<title>Video abstract</title>
<p>
<media id="d35e96" mimetype="video" position="anchor" xlink:href="ceg-10-091-s.avi" xlink:type="simple"></media></p>
</abstract>
<kwd-group>
<title>Keywords</title>
<kwd>gastrointestinal</kwd>
<kwd>commensal</kwd>
<kwd>symbiotic</kwd>
<kwd>pathogenic microorganisms</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>The word “microbiome” was first coined by American Molecular Biologist Dr Joshua Lederberg to imply the environmental and biological community of commensal, symbiotic, and pathogenic microorganisms that share human body space and have been all but ignored as elements of health and disease.<xref ref-type="bibr" rid="b1-ceg-10-091">1</xref> The microbiome is defined as the overall collection of microbiota that resides inside humans or on their skin surface.<xref ref-type="bibr" rid="b2-ceg-10-091">2</xref>–<xref ref-type="bibr" rid="b5-ceg-10-091">5</xref> It has been recognized for some time that the human body is colonized by at least ten times more bacteria than the figure of human cells in the body and that most of these bacteria live in the human gastrointestinal (GI) territory.<xref ref-type="bibr" rid="b6-ceg-10-091">6</xref>–<xref ref-type="bibr" rid="b8-ceg-10-091">8</xref> It has been estimated that ~10–100 trillion commensal bacteria occupy the human GI tract; therefore, the figure that vastly outnumbers the number of cells of human origin.<xref ref-type="bibr" rid="b5-ceg-10-091">5</xref>,<xref ref-type="bibr" rid="b8-ceg-10-091">8</xref>,<xref ref-type="bibr" rid="b9-ceg-10-091">9</xref> Nevertheless, “the total cell number of a human being ranges between 10<sup>2</sup> and 10<xref ref-type="bibr" rid="b16-ceg-10-091">16</xref> and it is widely mentioned without a proper reference.”<xref ref-type="bibr" rid="b10-ceg-10-091">10</xref> In a recent report, it was found that “the number of cells in the human microbiota is likely to be highly variable depending on nutritional input, body size, age, ethnicity, culture, and environment.”<xref ref-type="bibr" rid="b11-ceg-10-091">11</xref> Although worldwide most research has concentrated on microorganisms that cause disease and microbial drug resistance, due to unknown reasons, studies on the microbiome and their its benefits in the human body did has not had a similar prioritisation or urgency as those on pathogenic microorganismsin many communities and countries.<xref ref-type="bibr" rid="b7-ceg-10-091">7</xref>,<xref ref-type="bibr" rid="b12-ceg-10-091">12</xref>–<xref ref-type="bibr" rid="b19-ceg-10-091">19</xref> There are an innumerable variety of microorganisms in nature, many of which can cause diseases in humans. However, the human body is a host to a great number and assortment of bacteria, viruses,<xref ref-type="bibr" rid="b20-ceg-10-091">20</xref> and fungi,<xref ref-type="bibr" rid="b21-ceg-10-091">21</xref> which are beneficial to health and well-being. It has been reported that the normal inhabitant bacterial flora of the human body is poorly understood.<xref ref-type="bibr" rid="b22-ceg-10-091">22</xref>–<xref ref-type="bibr" rid="b25-ceg-10-091">25</xref> Although they are termed commensals, bacteria comprising the gut microbiome share a much stronger relationship with the human host than the term suggests.<xref ref-type="bibr" rid="b26-ceg-10-091">26</xref>–<xref ref-type="bibr" rid="b29-ceg-10-091">29</xref> Commensalism is a form of symbiosis whereby one organism gains from its association with another organism, whereas the other is affected in neither a positive nor a deleterious manner. There is more of a mutualistic nature to the bond shared by human host and bacterial colonizers in that the relationship benefits both parties: the microbiome is provided with an environment to live in and a readily available source of nutrients, and the human receives metabolites from bacterial digestion which it could not have otherwise obtained.<xref ref-type="bibr" rid="b29-ceg-10-091">29</xref>–<xref ref-type="bibr" rid="b31-ceg-10-091">31</xref> As the human hostages, the gut microbiome gains a level of stability that suggests a strong interrelationship between host and bacteria, which has evolved over a substantial period.<xref ref-type="bibr" rid="b32-ceg-10-091">32</xref>,<xref ref-type="bibr" rid="b33-ceg-10-091">33</xref> In addition, in the process of digestion and metabolism, these bacteria play an important role in the immune system and other body functions.<xref ref-type="bibr" rid="b34-ceg-10-091">34</xref>,<xref ref-type="bibr" rid="b35-ceg-10-091">35</xref> Over the last 20 years, it has been shown that it is possible to modulate the composition and metabolic activities of the gut microbiome such that the health benefits to the host are maximized while reducing the deleterious effects of pathogenic organisms.<xref ref-type="bibr" rid="b34-ceg-10-091">34</xref>,<xref ref-type="bibr" rid="b36-ceg-10-091">36</xref>–<xref ref-type="bibr" rid="b39-ceg-10-091">39</xref> This has made the study of the microbiome a subject of great interest.</p>
</sec>
<sec>
<title>Anatomy of the gut and bacterial compositions</title>
<p>The GI tract starts at the mouth, connects to the esophagus and thence to the stomach and small and large intestines, and ends at the rectum. The GI tract can be visualized as a long tube that passes uninterrupted through the body from lips through to anus. The stomach, small bowel, and colon are the organs that constitute the gut. The large intestine is the most densely populated section of the GI tract. The stomach contains relatively low numbers of bacteria, primarily due to the acidic nature of gastric juice. Stomach contents are also retained for a relatively short time; therefore, the food supply for bacteria is limited. Despite this fact, microbial populations in the stomach can reach 10<sup>3</sup> organisms per gram of contents, rising to 10<sup>6</sup>/g after a meal, due to the buffering capacity of food.<xref ref-type="bibr" rid="b40-ceg-10-091">40</xref>,<xref ref-type="bibr" rid="b41-ceg-10-091">41</xref> The predominating microbial species are acid-tolerant lactobacilli and streptococci, which can withstand a low-pH environment to some extent.<xref ref-type="bibr" rid="b41-ceg-10-091">41</xref> Bacteria are considerably more numerous in the distal small bowel and large intestine. The transit of contents through the colon takes considerably longer time, which provides time for complex microbial communities to develop.<xref ref-type="bibr" rid="b42-ceg-10-091">42</xref> Currently, the microbe population living in the human intestine is named “gut microbiota” (previously known as “gut flora”).<xref ref-type="bibr" rid="b43-ceg-10-091">43</xref> Human gut microbiota comprises tens of trillions of microorganisms, counting at least 1,000 different species of known bacteria with more than three million genes (150 times more than human genes).<xref ref-type="bibr" rid="b43-ceg-10-091">43</xref>,<xref ref-type="bibr" rid="b44-ceg-10-091">44</xref> The most abundant species belong to the phyla Bacteroidetes and Firmicutes, which account for up to 90% of all the bacteria in the distal gut.<xref ref-type="bibr" rid="b45-ceg-10-091">45</xref> Human intestine accommodates multifarious-community microbial cells that have an impact on humanoid “physiology, metabolism, nutrition and immune function while disruption to the gut microbiota has been linked with GI conditions such as inflammatory bowel disease (IBD) and obesity.”<xref ref-type="bibr" rid="b37-ceg-10-091">37</xref></p>
</sec>
<sec>
<title>Digestion in the human gut</title>
<p>It was traditionally considered that the main function of the large intestine was principally the reclamation of water and salts and that it had little or no role in digestive processes, which occurred in the stomach and small intestine. However, it has been shown that a small, but significant contribution is made to digestive processes by the large gut, as modulated by the microbiome.</p>
<sec>
<title>Carbohydrate digestion</title>
<p>Carbohydrate catabolism (and, to a lesser extent, protein breakdown) yields short-chain fatty acids (SCFAs), and this is done by a process called fermentation, which is conducted by anaerobic bacteria in the gut.<xref ref-type="bibr" rid="b46-ceg-10-091">46</xref> Carbohydrates that can be grouped under the term “dietary fibers” are the most common sources of SCFAs, as well as starches that are not digested in the small intestine.<xref ref-type="bibr" rid="b47-ceg-10-091">47</xref>,<xref ref-type="bibr" rid="b48-ceg-10-091">48</xref> Dietary fibers are indigestible in humans; therefore, the fermenting actions of the gut microbiota generate SCFAs for human use. The three principal SCFAs found in the human body are butyrate, propionate, and acetate, in an approximate ratio of 1:1:3.<xref ref-type="bibr" rid="b49-ceg-10-091">49</xref> Approximately 95%–99% (the clear majority) of SCFAs produced in the gut are absorbed.<xref ref-type="bibr" rid="b50-ceg-10-091">50</xref> SCFAs, predominantly butyrate, are vital sources of energy for colonocytes, and up to 70% of their energy needs may be gained through fermentation.<xref ref-type="bibr" rid="b41-ceg-10-091">41</xref> It has been shown in mice that a lack of a microbiome, and therefore no production of butyrate, can lead to autophagy (self-digestion of cells in response to an energy and nutrient deficit) of the colon cells.<xref ref-type="bibr" rid="b9-ceg-10-091">9</xref>,<xref ref-type="bibr" rid="b51-ceg-10-091">51</xref>,<xref ref-type="bibr" rid="b52-ceg-10-091">52</xref> The colonocytes of these germ-free mice were also found to be energy-deficient, as well as having reduced levels of enzymes that catalyze reactions such as those in the citric acid cycle.<xref ref-type="bibr" rid="b51-ceg-10-091">51</xref> This highlights the importance of a microbiome and the substantial contribution they make to energy supply. The SCFAs are useful energy sources as well as playing a role in the human immune system. A recent study detected that SCFAs also regulate the immune system and inflammatory response.<xref ref-type="bibr" rid="b52-ceg-10-091">52</xref> They diminish the sensitivity of lamina propria macrophages to commensal bacteria, via nitric oxide, IL-6, and IL-12 independent of free fatty acid receptor signaling, to persuade tolerance.<xref ref-type="bibr" rid="b53-ceg-10-091">53</xref> The SCFAs, especially propionate and butyrate, have also been shown to inhibit the expression of lipopolysaccharide-induced cytokines, IL-6 and IL-12p40, in human mature dendritic cells.<xref ref-type="bibr" rid="b54-ceg-10-091">54</xref> The SCFAs, which were used therapeutically in inflammatory diseases in a controlled experimental setup, showed improvements in IBD and acute radiation proctitis, as it plays a direct anti-inflammatory role.<xref ref-type="bibr" rid="b55-ceg-10-091">55</xref>–<xref ref-type="bibr" rid="b57-ceg-10-091">57</xref> Propionate and acetate have been found to show an anti-inflammatory action on human monocytes by regulating cytokine and chemokine production, such as IL-10 and MCP-1.<xref ref-type="bibr" rid="b58-ceg-10-091">58</xref> MCP-1 is one of the key chemokines that regulate migration and infiltration of monocytes/macrophages.<xref ref-type="bibr" rid="b59-ceg-10-091">59</xref> Propionate and butyrate have also exhibited anticancer properties.<xref ref-type="bibr" rid="b60-ceg-10-091">60</xref>,<xref ref-type="bibr" rid="b61-ceg-10-091">61</xref></p>
</sec>
<sec>
<title>Protein digestion</title>
<p>The breakdown of protein by the gut microbiota also contributes to SCFA production, but not as profoundly as carbohydrate fermentation. However, this process releases a greater variety of end products such as hydrogen, carbon dioxide, ammonia, thiols, amines, indoles, and phenols. Many of these substances are considered toxic and have carcinogenic effects. Thus, protein catabolism is a less beneficial process compared with carbohydrate fermentation.<xref ref-type="bibr" rid="b41-ceg-10-091">41</xref> It can be noted that many large bowel diseases occur in the distal gut (ie, the descending and sigmoid colons). As food passes along the bowel, the most easily digestible material (carbohydrates) will be used up first; therefore, protein digestion becomes more important in the distal sections. Signature products of amino acid breakdown are branched-chain fatty acids (BCFAs), and it was found by the experiments conducted with human sudden death victims that the concentrations of BCFAs were notably higher in gut contents obtained from the distal large bowel than that of the proximal colon. SCFAs, produced during protein digestion, more than doubled from 17% to 38% in the distal large gut. This evidence points to protein breakdown and the production of toxic by-products as potential causes of diseases in the distal large gut.<xref ref-type="bibr" rid="b41-ceg-10-091">41</xref></p>
</sec>
</sec>
<sec>
<title>Modulation of the microbiome</title>
<p>As it is well established that a healthy gut microbiome has many positive effects on their human hosts and has influence on diseases, thoughts have turned to how to change and enhance the microbiome to gain further health benefits.</p>
<sec>
<title>Prebiotics</title>
<p>A prebiotic is defined as a nonviable food component that confers a health benefit on the host associated with the modulation of the microbiota.<xref ref-type="bibr" rid="b62-ceg-10-091">62</xref>,<xref ref-type="bibr" rid="b63-ceg-10-091">63</xref> Although most foodstuff will change the levels of bacteria in the gut,<xref ref-type="bibr" rid="b64-ceg-10-091">64</xref> nonviable food ingredients such as inulin, fructo-oligosaccharides, and galacto-oligosaccharides have a more specific effect on the growth of beneficial bacteria, such as bifidobacteria and lactobacilli.<xref ref-type="bibr" rid="b65-ceg-10-091">65</xref> Both are gram-positive anaerobes, which are specialized in the breakdown of carbohydrates in the gut.<xref ref-type="bibr" rid="b66-ceg-10-091">66</xref> As mentioned above, carbohydrate digestion produces SCFAs, which is beneficial to the gut. A few negative effects of prebiotics have been recorded, such as a slight laxative effect and flatulence from both inulin-derived oligosaccharides and galacto-oligosaccharides; however, this is only the case when significant quantities are consumed, and therefore, overall, the benefit far outweighs any potential drawbacks. To make a prebiotic function effectively, it must be able to pass undigested through the GI tract and to reach its target bacteria in the gut, where it can be fermented. Furthermore, the target bacteria themselves must be present in the gut for there to be any modulatory effect.<xref ref-type="bibr" rid="b67-ceg-10-091">67</xref> Many common foodstuffs such as onions, garlic, and bananas naturally contain oligosaccharides with prebiotic potential.<xref ref-type="bibr" rid="b68-ceg-10-091">68</xref> However, it is believed that these polysaccharides are present in a too low concentration to significantly alter the levels of bacteria in the gut. This has led to the initiative of extracting and purifying prebiotics and then fortifying common foodstuffs such as table spreads, drinks, and cereals.<xref ref-type="bibr" rid="b68-ceg-10-091">68</xref> This has been proven to be a less expensive method of modulating the gut microbiome than using probiotics.<xref ref-type="bibr" rid="b64-ceg-10-091">64</xref> Prebiotic compounds can be extracted from plant sources. Another technique to produce galacto-oligosaccharides is to break down lactose, an abundant by-product in the manufacture of dairy goods, using β-galactosidases.<xref ref-type="bibr" rid="b65-ceg-10-091">65</xref> This method consumes substrates that would otherwise have gone to waste as well as can produce the prebiotic.</p>
</sec>
<sec>
<title>Probiotics</title>
<p>Probiotics used in humans are live bacteria and yeasts, which are delivered to the gut via oral ingestion.<xref ref-type="bibr" rid="b67-ceg-10-091">67</xref> They are often ingredients in food products, which have a unique selling point, making them very popular with members of the public, but is there any truth in the usefulness of probiotics? Like prebiotics, to make probiotics effective, they must be resistant to digestion in the upper gut, such that they can reach sections of the bowel where they can seed and grow.<xref ref-type="bibr" rid="b67-ceg-10-091">67</xref> Probiotics have been shown to confer beneficial effects on the host. They compete with pathogenic microbes for nutrients and space to grow, inhibiting pathogenic growth.<xref ref-type="bibr" rid="b69-ceg-10-091">69</xref> Furthermore, some probiotics such as bifidobacteria, but mainly lactobacilli, produce peptides called bacteriocins that have antimicrobial properties and are used to kill pathogenic bacteria.<xref ref-type="bibr" rid="b70-ceg-10-091">70</xref> Although several research reports have confirmed that the consumption of probiotics has numerous health benefits,<xref ref-type="bibr" rid="b71-ceg-10-091">71</xref>–<xref ref-type="bibr" rid="b74-ceg-10-091">74</xref> nevertheless, “health authorities have only approved claims on (a) lactose intolerance and lactose digestion and (b) cholesterol reduction mostly because of biomarker deficiency.”<xref ref-type="bibr" rid="b75-ceg-10-091">75</xref> The risk of myocardial infarction is three times higher in those with a high lipid profile than in those with normal levels of blood lipids.<xref ref-type="bibr" rid="b76-ceg-10-091">76</xref> The cholesterol-reducing ability of probiotics has been extensively studied and has revealed that total plasma cholesterol and low-density lipoprotein cholesterol can be reduced by 7.84% and 9.27%, respectively.<xref ref-type="bibr" rid="b77-ceg-10-091">77</xref>,<xref ref-type="bibr" rid="b78-ceg-10-091">78</xref> Existing accessible antimicrobial treatments for yeast vaginitis, candidiasis, bacterial vaginosis, and urinary tract infection can often lead to a number adverse drug reactions, such as diarrhea, superinfections, depression, and even renal failure.<xref ref-type="bibr" rid="b75-ceg-10-091">75</xref> Moreover, antimicrobial resistance inclines to decline the usefulness of this therapy over time.<xref ref-type="bibr" rid="b17-ceg-10-091">17</xref>–<xref ref-type="bibr" rid="b19-ceg-10-091">19</xref> Lactobacilli have been shown to create biosurfactants and collagen-binding proteins that inhibit pathogen adhesion to the vaginal wall. This actually explains the reason why the vaginal mucosa is conquered by lactobacilli, making access to pathogens problematic.<xref ref-type="bibr" rid="b79-ceg-10-091">79</xref> Probiotics available in the marketplace for oral health include species of Lactobacillus and Bifidobacterium.<xref ref-type="bibr" rid="b80-ceg-10-091">80</xref> Several studies have demonstrated that Lactobacillus and Bifidobacterium can decrease the oral levels of the cariogenic species <italic>Streptococcus mutans</italic>.<xref ref-type="bibr" rid="b81-ceg-10-091">81</xref>–<xref ref-type="bibr" rid="b84-ceg-10-091">84</xref>
<italic>Streptococcus salivarius</italic> K12 has also been recognized to generate several proteins that are active against closely related strain (bacteriocins) such as <italic>Streptococcus pyogenes</italic> and <italic>Streptococcus pneumonia</italic> and avert repeated pharyngitis, otitis media, and tonsillitis.<xref ref-type="bibr" rid="b85-ceg-10-091">85</xref>,<xref ref-type="bibr" rid="b86-ceg-10-091">86</xref> Microbial β-galactosidase in yogurt is resistant to gastric acid and supports lactose digestion.<xref ref-type="bibr" rid="b75-ceg-10-091">75</xref> Multiple studies detected that the symptoms of lactose malabsorption improved due to extra production of β-galactosidase by probiotic cultures.<xref ref-type="bibr" rid="b87-ceg-10-091">87</xref>,<xref ref-type="bibr" rid="b88-ceg-10-091">88</xref> Furthermore, it has been observed that milk containing <italic>Lactobacillus acidophilus</italic> also aids lactose absorption and shows improvement in lactose-intolerant patients.<xref ref-type="bibr" rid="b89-ceg-10-091">89</xref> Probiotic supplementation can also modify the quantity of colonic microbiota and improve symptoms in lactose-intolerant subjects.<xref ref-type="bibr" rid="b90-ceg-10-091">90</xref></p>
</sec>
<sec>
<title>Symbiotics</title>
<p>A symbiotic is a combination of a prebiotic and a probiotic.<xref ref-type="bibr" rid="b91-ceg-10-091">91</xref> There is a sound logic behind the symbiotic concept; the probiotic component will aid in metabolism and host immunity, whereas the prebiotic selectively stimulates the growth of the probiotic, and other beneficial bacteria already extant in the gut. Overall gut health is positively modulated. The effectiveness of symbiotics has been investigated in several diseases. The symbiotic therapy involving <italic>Bifidobacterium longum</italic> and Synergy 1 has been shown to have benefits to both Crohn’s disease (CD) and ulcerative colitis (UC) patients. <italic>B. longum</italic> was chosen from a selection of nineteen bifidobacterial strains. This choice was made based on testing for desired characteristics: aerotolerance, acid tolerance, bile salt resistance, adhesion to epithelial cells, and ability to use oligofructose as an energy source, as well as a capacity to withstand freeze-drying and storage. The bacterium that predominated in all categories was <italic>B. longum</italic>.<xref ref-type="bibr" rid="b92-ceg-10-091">92</xref> Synergy 1 is made from inulin from the chicory plant and oligofructose.<xref ref-type="bibr" rid="b67-ceg-10-091">67</xref> Another important bacterium is <italic>Faecalibacterium prausnitzii</italic>, which is found in ample quantity (5% of the total bacterial population) in the human intestinal microbiota of healthy adults.<xref ref-type="bibr" rid="b93-ceg-10-091">93</xref> This species is a highly functionally active member of the microbiome, influencing numerous host pathways.<xref ref-type="bibr" rid="b94-ceg-10-091">94</xref> Several intestinal disorders were noticed to contain low numbers of <italic>F. prausnitzii</italic>, particularly in IBD patients.<xref ref-type="bibr" rid="b93-ceg-10-091">93</xref>,<xref ref-type="bibr" rid="b95-ceg-10-091">95</xref> Hence, the number of intestinal <italic>F. prausnitzii</italic> can be recommended as an indicator of intestinal health.<xref ref-type="bibr" rid="b93-ceg-10-091">93</xref>–<xref ref-type="bibr" rid="b95-ceg-10-091">95</xref> Immunologic dysregulation is the reason of numerous noninfectious human illnesses. The GI tract is the principal location of contact between the “host immune system and microorganisms, both symbiotic and pathogenic.”<xref ref-type="bibr" rid="b96-ceg-10-091">96</xref> Intestinal bacteria are considered for the development and function of the immune system. From the clinical, epidemiological, and immunological evidence, it was concluded that the absence of valuable microorganisms that sponsor appropriate immune development leads to the inflammatory responses including IBDs.<xref ref-type="bibr" rid="b97-ceg-10-091">97</xref></p>
</sec>
<sec>
<title>Diet-related dysbiosis, coeliac diseases, gluten-free diet (GFD), breast milk, western diet, and polyphenols</title>
<p>The impact of food on the arrangement of the microbiota has been shown during the preliminary colonization phase: breastfed newborns have advanced levels of <italic>Bifidobacteria</italic> spp., whereas formula-fed infants have higher levels of <italic>Bacteroides</italic> spp., as well as amplified <italic>Clostridium coccoides</italic> and <italic>Lactobacillus</italic> spp.<xref ref-type="bibr" rid="b98-ceg-10-091">98</xref> The microbiota was assumed to maintain a relatively steady state all the way through life after the postnatal epoch. Nevertheless, quite a recent study have revealed that dietary influences modify the microbial community, resulting in biological deviations to the host.<xref ref-type="bibr" rid="b99-ceg-10-091">99</xref> It is extensively documented that the intestinal microbiota plays a role in preventing the commencement and continuation of intestinal inflammation in an ample number of chronic intestinal diseases.<xref ref-type="bibr" rid="b100-ceg-10-091">100</xref> Several studies reported that Celiac disease (CeD) patients with GI indicators are also recognized to have an altered microbiota.<xref ref-type="bibr" rid="b101-ceg-10-091">101</xref>–<xref ref-type="bibr" rid="b104-ceg-10-091">104</xref> It has been observed that the numbers of <italic>Bifidobacterium</italic> spp. and <italic>B. longum</italic> were significantly reduced, and the numbers of <italic>Bacteroides</italic> spp. were increased in stools and duodenal biopsies of CeD patients, untreated and treated with a GFD, compared with control subjects.<xref ref-type="bibr" rid="b101-ceg-10-091">101</xref>,<xref ref-type="bibr" rid="b102-ceg-10-091">102</xref> In addition, specific bacterial strains isolated from patients with active and nonactive CeD have been shown to have augmented virulence features. These outcomes recommended that microbiota modifications are of significance to the inflammatory status characteristics of the vigorous stage of the disease. These alterations could perform both a secondary role by enraging CeD pathogenesis and engendering a vicious circle and a primary role in contributing to disease onset.<xref ref-type="bibr" rid="b100-ceg-10-091">100</xref> Diet is the most important eco-friendly factor impelling gut microbiota multiplicity and functionality, which might be pertinent to subjects following dietary remedies. The CeD is an enteropathy caused by an atypical immune response to cereal gluten proteins, and the solitary therapy is the obedience to a GFD.<xref ref-type="bibr" rid="b105-ceg-10-091">105</xref> Human milk is a comprehensive source of sustenance for the newborn.<xref ref-type="bibr" rid="b106-ceg-10-091">106</xref> Human microbial colonization commences at birth and progresses and modifies in species profusion for ~3 years while waiting for the microbiota to grow into adult form. Toddlers go through noteworthy, evolving ups and downs of microbial colonization that encourage their health status as well as their immune system.<xref ref-type="bibr" rid="b107-ceg-10-091">107</xref> Exclusive breastfeeding for 6-months encourages the infant’s progress towards the multiplying of a defensive intestinal microbiota. The milk glycans among the many components of milk have been identified as chauffeurs of microbiota development and overall gut health because of its inherent properties of pleiotropic functions, conferring protection against infectious diseases.<xref ref-type="bibr" rid="b106-ceg-10-091">106</xref> Furthermore, intestinal permeability in preterm infants characterizes a life-threatening balance between the absorption of nutritional agents and protection from dangerous pathogens. Newborns who received either exclusive or a majority of feeding as human milk revealed significantly lower intestinal permeability when compared to infants receiving minimal or no human milk in postnatal days.<xref ref-type="bibr" rid="b108-ceg-10-091">108</xref> Western diet, which contains highly refined haphazard foods with poor nutritional quality essentially constituting sugar and fat, causes dysbiosis that upsets both host GI tract metabolism and immune homeostasis.<xref ref-type="bibr" rid="b109-ceg-10-091">109</xref>–<xref ref-type="bibr" rid="b111-ceg-10-091">111</xref> Another study highlighted typical Western diet converts the microbiota composition shifting to an overgrowth of Firmicutes including <italic>Clostridium innocuum</italic>, <italic>Eubacterium dolichum</italic>, <italic>Catenibacterium mitsuokai</italic>, and <italic>Enterococcus</italic> spp., as well as a significant reduction in several <italic>Bacteroides</italic> spp.; however, traditional food regimes rich in plant polysaccharides are linked with a Prevotella enterotype.<xref ref-type="bibr" rid="b52-ceg-10-091">52</xref>,<xref ref-type="bibr" rid="b112-ceg-10-091">112</xref> It also reported that such a typical diet can cause 71% upsurge in plasma levels of endotoxins, proposing that endotoxemia may progress in folks with GI barrier dysfunction associated with dysbiosis.<xref ref-type="bibr" rid="b113-ceg-10-091">113</xref> Dietary polyphenols extant in a wide-range of vegetables and fruits have been associated with positive health benefits.<xref ref-type="bibr" rid="b114-ceg-10-091">114</xref>,<xref ref-type="bibr" rid="b115-ceg-10-091">115</xref> It has also been reported that variances in the dispersal of bacteria are linked with dietary habits and this in reality provocates and promotes the host to be exposed to microbial metabolites.<xref ref-type="bibr" rid="b115-ceg-10-091">115</xref> Another group of scientist revealed that the gut microbiome of children living in remote West African countries was significantly different from that of the children of the same age from the most sophisticated European countries.<xref ref-type="bibr" rid="b116-ceg-10-091">116</xref> Similar observation of differences in gut microbiome was found between communities, in rural and urban areas, and residents in non-industrialized and industrialized societies.<xref ref-type="bibr" rid="b117-ceg-10-091">117</xref>,<xref ref-type="bibr" rid="b118-ceg-10-091">118</xref> Multiple studies reported that dietary polyphenols are entrusted to conserve the intestinal health by protecting the gut microbial equilibrium through the encouragement of the development of beneficial bacteria (ie, lactobacilli and bifidobacteria) and the inhibition of pathogenic bacteria, wielding prebiotic-like properties.<xref ref-type="bibr" rid="b119-ceg-10-091">119</xref>–<xref ref-type="bibr" rid="b125-ceg-10-091">125</xref></p>
</sec>
<sec>
<title>Fecal microbiota transplantation (FMT)</title>
<p>FMT (or bacteriotherapy) is the relocation of stool from a healthy giver into the GI tract with the determination of treating recurrent <italic>Clostridium difficile</italic> colitis.<xref ref-type="bibr" rid="b126-ceg-10-091">126</xref>
<italic>C. difficile</italic> infection (CDI) is the leading cause of antibiotic-associated diarrhea, and the infection rates are increasing.<xref ref-type="bibr" rid="b127-ceg-10-091">127</xref>–<xref ref-type="bibr" rid="b129-ceg-10-091">129</xref> CDI treatment choices are restricted and seem to lose efficacy due to resistance. Recurrent disease is particularly puzzling; extended treatment with oral vancomycin (Eli Lilly and Company, Indianapolis, IN, USA) is becoming increasingly common, but is expensive.<xref ref-type="bibr" rid="b127-ceg-10-091">127</xref> The emergence of the hypervirulent <italic>C. difficile</italic> strain has been related to a rise in disease severity, with mortality reported in up to 6.9% of cases.<xref ref-type="bibr" rid="b130-ceg-10-091">130</xref> The associated economic burden is also significant.<xref ref-type="bibr" rid="b128-ceg-10-091">128</xref> Nosocomial CDI upsurges the cost of treatment by fourfold, translating to a cost reported up to $4.8 billion/year in the USA.<xref ref-type="bibr" rid="b131-ceg-10-091">131</xref>,<xref ref-type="bibr" rid="b132-ceg-10-091">132</xref> FMT embraces substantial potential as a therapy for recurrent CDI with very minimum cost, but still requires more research.<xref ref-type="bibr" rid="b127-ceg-10-091">127</xref>–<xref ref-type="bibr" rid="b129-ceg-10-091">129</xref></p>
</sec>
</sec>
<sec>
<title>Microbiome and its relationship to disease</title>
<sec>
<title>IBD</title>
<p>IBD is a general term used to define many conditions that cause inflammation of the GI tract, with the two main forms being UC and CD. Both are chronic illnesses that are characterized by inflammation, which often goes into remission and then flares up throughout the sufferer’s lifetime. A study conducted in Germany tested the hypothesis of a genetic link in IBD. Monozygotic twins were found to have a tenfold increased risk of developing the condition than dizygotic twins, emphasizing a strong genetic link in sufferers of IBD, especially CD.<xref ref-type="bibr" rid="b133-ceg-10-091">133</xref> Recent advances have provided substantial insight into genetic relation with IBD. Epidemiological data shows the prevalence among different geographical areas, ethnic groups, familial predisposition, and concordance in twins.<xref ref-type="bibr" rid="b134-ceg-10-091">134</xref>,<xref ref-type="bibr" rid="b135-ceg-10-091">135</xref> IBD is a peaks-and-valleys disease categorized by diarrhea, abdominal pain, and weight loss.<xref ref-type="bibr" rid="b135-ceg-10-091">135</xref> Recently, it has been observed that IBD has a strong correlation with sleep, circadian rhythms, and melatonin.<xref ref-type="bibr" rid="b136-ceg-10-091">136</xref> Sleep disorders have become a global issue; currently, in modern society, lack of sleep, shift work, or circadian misalignment is an extremely common issue. The total sleep time has increasingly declined over the last 25 years as the change of work environment, frequent long flights, and mobility have been internationally altered and posed a challenge to human circadian homeostasis.<xref ref-type="bibr" rid="b137-ceg-10-091">137</xref>,<xref ref-type="bibr" rid="b138-ceg-10-091">138</xref> Insomnia and other sleep disorders are associated with many serious adverse health miseries, economic consequences, and, furthermost significantly, has amplified all-cause mortality.<xref ref-type="bibr" rid="b139-ceg-10-091">139</xref> It has been observed that there is a strong correlation between sleep and the immune system. Although the total issue regarding sleep and immunity is complex and poorly understood,<xref ref-type="bibr" rid="b139-ceg-10-091">139</xref> sleep strengthens immune function<xref ref-type="bibr" rid="b131-ceg-10-091">131</xref> and deprivation has been shown to have damaging effects on the immune system and can lead to leukocytosis and an increase in natural killer cells, which can lead to increased inflammatory cytokine production.<xref ref-type="bibr" rid="b140-ceg-10-091">140</xref>–<xref ref-type="bibr" rid="b142-ceg-10-091">142</xref> Environmental factors were also considered as an indispensable gear of the pathogenesis of IBD and chiefly accountable for its mounting incidence worldwide.<xref ref-type="bibr" rid="b143-ceg-10-091">143</xref> Many environmental hazardous aspects have been identified “including smoking, appendectomy, oral contraceptives, diet, breastfeeding, infections/vaccinations, antibiotics, and childhood hygiene.”<xref ref-type="bibr" rid="b142-ceg-10-091">142</xref> None of these environmental factors were isolated as the definite cause of IBDs.<xref ref-type="bibr" rid="b143-ceg-10-091">143</xref>,<xref ref-type="bibr" rid="b144-ceg-10-091">144</xref> The identification of various alterations of the gut microbiota composition in IBD has enabled using very advanced next-generation sequencing technology.<xref ref-type="bibr" rid="b145-ceg-10-091">145</xref> Alterations in the ecological system have been reported within the gut, that is, intestinal microbes and the immune system.<xref ref-type="bibr" rid="b146-ceg-10-091">146</xref>,<xref ref-type="bibr" rid="b147-ceg-10-091">147</xref> “The most consistent observation in IBD is reduced bacterial diversity, a decrease of Firmicutes, and an increase of Proteobacteria.”<xref ref-type="bibr" rid="b145-ceg-10-091">145</xref> Although many factors such as “host, genetic, and environmental” influences have been identified as for the pathogenesis of IBD,<xref ref-type="bibr" rid="b140-ceg-10-091">140</xref> currently, only smoking has been identified as the most potential and specific environmental factor for the onset of IBD.<xref ref-type="bibr" rid="b148-ceg-10-091">148</xref>–<xref ref-type="bibr" rid="b150-ceg-10-091">150</xref></p>
</sec>
<sec>
<title>CD</title>
<p>CD is a patchy transmural inflammation in the GI tract, which is found anywhere from the mouth to the rectum. Typically, the most common sites of inflammation are the distal sections of the small intestine such as the ileum and the colon. The severity of the condition can range from no symptoms at all (during times of remission) to acutely life-threatening.<xref ref-type="bibr" rid="b151-ceg-10-091">151</xref> Epidemiologically, the condition is most prevalent in the developed nations of Europe and the USA, with significantly lower incidence in the Southern Hemisphere.<xref ref-type="bibr" rid="b152-ceg-10-091">152</xref> Although the pathology and physiology involved in CD are not completely understood, there appear to be many factors that predispose to the condition: bacterial activity in the gut, genetic susceptibility, and irregular immune response.<xref ref-type="bibr" rid="b151-ceg-10-091">151</xref>,<xref ref-type="bibr" rid="b152-ceg-10-091">152</xref> The inflammatory response found in CD is defined by the release of type 1 helper T-cell cytokines, namely tumor necrosis factor-alpha (TNF-α), interferon gamma (IFN-γ), and IL-12.<xref ref-type="bibr" rid="b151-ceg-10-091">151</xref> The traditional treatments for CD are steroids, anti-inflammatory drugs, and, in particularly severe cases, surgical resection of inflamed portions of the bowel, with ~70% of sufferers requiring surgical intervention during their lifetime.<xref ref-type="bibr" rid="b151-ceg-10-091">151</xref> However, there is an increasing interest in alternative therapies involving probiotics, prebiotics, and symbiotics. Probiotics have been extensively tested, with varying results. For example, <italic>Lactobacillus</italic> GG was found not to reduce the rates of recurrence in the disease, and Nissle 1917, a strain of <italic>Escherichia coli</italic>, was found to promote quicker remission of the disease, but not to affect the rates of remission between subjects.<xref ref-type="bibr" rid="b67-ceg-10-091">67</xref> The use of prebiotics, on the other hand, has not been explored as deeply, and the few studies conducted have been little more than pilot studies. Symbiotics have shown more potential than either probiotics or prebiotics in isolation. A double-blind randomized control trial was conducted on 35 patients with CD to ascertain the effectiveness of the symbiotic therapy comprising <italic>B. longum</italic> and Synergy 1.<xref ref-type="bibr" rid="b153-ceg-10-091">153</xref> In the present study, appropriately selected subjects ingested either the symbiotic or a placebo every day, for the duration of 6 months. Patients were required to keep a bowel habit diary for the duration of the test. Furthermore, at the beginning, 3 months, and finally 6 months into the study, patients were required to undertake a Crohn’s disease activity index (CDAI) assessment, fill out an IBD lifestyle questionnaire, and undergo flexible sigmoidoscopy or colonoscopy. Biopsies were taken for histological analysis. The study found that there were significant improvements in the CDAI and histological scores of the symbiotic group compared with the placebos. The numbers of <italic>B. longum</italic> in the gut mucosa were found in higher abundance coupled with larger populations of other bifidobacteria. Another important finding was that after 3 months of therapy, the levels of TNF-α (the principal inflammatory cytokine in CD) were markedly reduced in the symbiotic group. However, the reduction in TNF-α was not as significant at the 6-month check-up. Overall, this study showed that symbiotics have the potential to be a viable treatment for CD, which may become more commonplace with time and development.</p>
</sec>
<sec>
<title>Ulcerative colitis</title>
<p>UC is one of the two main forms of IBD and is characterized by the formation of ulcers in the lining of the colon and rectum, with patients usually presenting with diarrhea, and with mucus and blood in their stools.<xref ref-type="bibr" rid="b154-ceg-10-091">154</xref> It is distinct from CD in terms of site, presentation, and histology. The condition also exhibits more of a type 2 helper T-cell-mediated response, with the production of cytokines such as TNF-α, IL-1α, IL-1β, IL-5, IL-8, and IFN-γ.<xref ref-type="bibr" rid="b91-ceg-10-091">91</xref> These cytokines recruit neutrophils and monocytes into the mucosa via chemotaxis. As with CD, the etiology is not fully understood, but there is evidence that points to an inappropriate inflammatory response to the gut microbiome. The main classes of drugs used to treat UC are aminosalicylates, corticosteroids, and immunosuppressant, with many patients eventually requiring a colectomy.<xref ref-type="bibr" rid="b154-ceg-10-091">154</xref> Probiotics such as VSL#3 (a combination of eight different probiotic bacteria) were found to induce remission in 93% of subjects compared with 36% of the placebo group. Furthermore, the rates of relapse were considerably higher (73%) in the placebo group and only 21% to those on the probiotic course. These are quite convincing figures to the effectiveness of VSL#3; however, it is worth noting that this study was conducted on a cohort of children and adolescents, and the efficacy in adults may not necessarily be the same.<xref ref-type="bibr" rid="b155-ceg-10-091">155</xref> Multiple studies reported that still there is doubt regarding VSL#3 efficacy and thereafter more research is suggested.<xref ref-type="bibr" rid="b156-ceg-10-091">156</xref>–<xref ref-type="bibr" rid="b158-ceg-10-091">158</xref> As with CD, the combination therapy of <italic>B. longum</italic> and Synergy 1 has been tested on UC patients. After 4 weeks of therapy, the symbiotic group was found to have improved sigmoidoscopy scores and substantially reduced levels of IL-1α and TNF-α (which are usually elevated in UC patients). A drop in the concentrations of inducible human beta defensins (hBD) was also recorded in the symbiotic group. This is a strong indicator that the inflammation was reduced, as hBD is only produced and released by epithelial tissue when inflamed. It was also noted that the numbers of bifidobacteria in the gut had increased by ~42 times their original number.<xref ref-type="bibr" rid="b152-ceg-10-091">152</xref> Overall, there was an improvement in bowel activity and positive clinical findings that lay down a foundation for further development of symbiotic treatment.</p>
</sec>
<sec>
<title>Irritable bowel syndrome (IBS)</title>
<p>IBS is a chronic illness characterized by the presence of abdominal pain or discomfort, which may be associated with an increased frequency of defecation and/or accompanied by a change in bowel habit as stated in the National Institute for Health and Clinical Excellence Guidelines.<xref ref-type="bibr" rid="b159-ceg-10-091">159</xref> The etiology of this condition is poorly understood, with possible causes ranging from mal-fermentation of food substrates to psychosocial factors such as stress.<xref ref-type="bibr" rid="b160-ceg-10-091">160</xref> However, it is noted that almost half of the IBS sufferers can identify a definitive event before their symptoms began, for example, surgery, the use of antibiotic drugs, or a spell of gastritis. These are all known to disturb the gut microbiome; therefore, it is hypothesized that this disruption to the bacteria is key to the pathogenesis of IBS.<xref ref-type="bibr" rid="b161-ceg-10-091">161</xref> Investigations have shown that the composition of the microbiome in IBS patients differs from the norm with a higher presence of facultatively anaerobic microorganisms such as <italic>Streptococcus</italic> spp., <italic>E. coli</italic>, and <italic>Proteus</italic> spp. Conversely, lactobacilli and bifidobacterial populations were reduced compared with nonsufferers.<xref ref-type="bibr" rid="b161-ceg-10-091">161</xref> Due to the potential importance of the microbiome in this condition, the idea to modulate it with probiotics and prebiotics presents itself. Many studies have been conducted, but the results are yet being not conclusive, but it shows some promise.</p>
</sec>
</sec>
<sec>
<title>Bacteria in the body over time</title>
<sec>
<title>Neonates</title>
<p>The gut microbiome, and principally the study of its ancestries in neonates, have become subtopics of great curiosity within the arena of genomics.<xref ref-type="bibr" rid="b162-ceg-10-091">162</xref> The human body does not develop a microbiome until after birth; the sterile nature of the womb prevents microbial colonization until birth. It has been shown in studies conducted in Finland,<xref ref-type="bibr" rid="b163-ceg-10-091">163</xref> as well as in India,<xref ref-type="bibr" rid="b164-ceg-10-091">164</xref> that the method of delivery affects the composition and development of the microbiome. Colonization of mucosa in the digestive, respiratory, urogenital tracts, as well as the skin, begins at, or perhaps even before, the time of birth when a newborn is exposed to a mother’s microbiota.<xref ref-type="bibr" rid="b165-ceg-10-091">165</xref> Beforehand it was believed that the utero environment was mostly sterile and that a fetus was not colonized with bacteria until the time of birth.<xref ref-type="bibr" rid="b165-ceg-10-091">165</xref> Babies born by natural means, that is, gain their bacteria from the vaginal tract and fecal matter of the mother, resulting in a more regular and healthy microbiome. The species most commonly found in this community are <italic>Acinetobacter</italic> spp., <italic>Bifidobacterium</italic> spp., and <italic>Staphylococcus</italic> spp. On the other hand, the species of bacteria found in babies who were delivered by caesarean section (C-section) are more influenced by bacteria from the mother’s skin and the general environment. There is also more chance of unwanted opportunistic invaders colonizing the newborn, to occupy niches that would normally have been inhabited by commensals. Prevailing species in C-section neonates were <italic>Citrobacter</italic> spp., <italic>E. coli</italic>, and <italic>C. difficile</italic>. A notable deficit in bifidobacterial species was also detected. These organisms are known to be very beneficial to the human host. It was also found that <italic>Bacteroides</italic> spp., which usually colonize a newborn within 3–10 days from birth,<xref ref-type="bibr" rid="b31-ceg-10-091">31</xref> were still present in very low numbers, even 6 months into the life of the child, showing a significant delay in colonization. It has been suggested that this departure from normal gut microbiota composition and delayed colonization of beneficial commensals in babies, due to procedures such as C-sections, which need extra antiseptic measures for surgical interventions, as well as a general culture of sanitation and hygiene, has contributed to the allergy burden carried by many Western nations. Recent study pigeonholed a placental microbiome profile and found that nonpathogenic commensal microbiota from the Firmicutes, Tenericutes, Proteobacteria, Bacteroidetes, and Fusobacteria phyla.<xref ref-type="bibr" rid="b166-ceg-10-091">166</xref> Thereafter, it was reported that within the first week of life, the full-term neonatal gut microbiome is largely colonized by Actinobacteria, Proteobacteria, Bacteroidetes, and, much less, Firmicutes phyla.<xref ref-type="bibr" rid="b165-ceg-10-091">165</xref>,<xref ref-type="bibr" rid="b166-ceg-10-091">166</xref> Oversterilizations of our environment, a lower incidence of disease, as well as changes to diet have resulted in lowered exposure to pathogens and antigens and have led to a change in the communities of friendly bacteria that live inside humans. This has possibly led to higher incidences of atopic conditions and leads to the concept of good dirt and that commensal bacteria in early life can defend against future occurrences of allergy.<xref ref-type="bibr" rid="b167-ceg-10-091">167</xref> Breast milk has been found to have significant prebiotic properties to the microbiome of infants.<xref ref-type="bibr" rid="b168-ceg-10-091">168</xref>,<xref ref-type="bibr" rid="b169-ceg-10-091">169</xref> Oligosaccharides constitute the third highest concentration of all nutrients that make up breast milk. Mammalian enzymes are unable to digest oligosaccharides, which led to the thinking that these carbohydrates were there to satisfy the nutritional needs of commensal bacteria, rather the child itself.<xref ref-type="bibr" rid="b170-ceg-10-091">170</xref>–<xref ref-type="bibr" rid="b172-ceg-10-091">172</xref> In an experiment, it was shown that the growth of two strains of bifidobacteria, <italic>B. longum</italic> ATCC 15697 and <italic>B. longum</italic> JCM 7007, was promoted when given human milk oligosaccharides (HMOs). Conversely, when HMOs were supplied to <italic>Clostridium perfringens</italic>, a pathogen that is one of the most common causes of food poisoning, an inhibitory effect was noted.<xref ref-type="bibr" rid="b173-ceg-10-091">173</xref> Finally, the maternal microbiota outlines the immune scheme of the progenies. Maternal colonization reprograms intestinal transcriptional silhouettes of the descendants, including amplified expression of genes encoding epithelial antibacterial peptides and metabolism of microbial molecules.<xref ref-type="bibr" rid="b174-ceg-10-091">174</xref></p>
</sec>
<sec>
<title>The elderly</title>
<p>The microbiome changes significantly as time passes and the age of the human host increases. There has been found to be greater differences in the gut communities of individuals aged &gt;65 years, than that in younger adults.<xref ref-type="bibr" rid="b175-ceg-10-091">175</xref>,<xref ref-type="bibr" rid="b176-ceg-10-091">176</xref> This may be attributed to a greater variation in diets of geriatrics dependent on their social situation and environment.<xref ref-type="bibr" rid="b110-ceg-10-091">110</xref>,<xref ref-type="bibr" rid="b177-ceg-10-091">177</xref> An experiment was conducted – a test group of elderly subjects (mean age =78 years) was selected and classified into four groups, ranging from community-residing individuals to those in long-term residential care, two ends of a spectrum. A small number of young healthy adults (mean age =36 years) were also included in the study for comparison purposes.<xref ref-type="bibr" rid="b177-ceg-10-091">177</xref> Food diaries of dietary intake were kept by each individual, and an analysis of bacteria in their fecal material was conducted. It was found that community-dwelling subjects had the healthiest microbiomes, which were akin to those of the younger cohort of test subjects.<xref ref-type="bibr" rid="b177-ceg-10-091">177</xref> On the other hand, microbiomes of the long-term residential group were the most removed from those of a healthy adult, with a lower diversity of the species of bacteria present.<xref ref-type="bibr" rid="b177-ceg-10-091">177</xref> An analysis for SCFA production was also conducted, which showed that the bacteria of community subjects possessed more genes that coded for enzymes that produce SCFA than those of long-term residents.<xref ref-type="bibr" rid="b177-ceg-10-091">177</xref> When this data is compared with the diets of the subjects, it becomes more apparent from where this disparity stems.<xref ref-type="bibr" rid="b177-ceg-10-091">177</xref> Most community geriatric diets came under the category of high fiber/low fat, whereas long-term subjects fell under low fiber/high fat, with the biggest differences in food intake revolving around fruit, vegetables, and meat.<xref ref-type="bibr" rid="b110-ceg-10-091">110</xref>,<xref ref-type="bibr" rid="b177-ceg-10-091">177</xref>,<xref ref-type="bibr" rid="b178-ceg-10-091">178</xref> This shows that diverse and healthy diet results in a similarly positive microbiome and vice versa. Another study has shown that the gut bacteria composition of centenarians differs significantly from that of young or elderly humans.<xref ref-type="bibr" rid="b179-ceg-10-091">179</xref></p>
</sec>
</sec>
<sec>
<title>Conclusion</title>
<p>A multiplicity of studies involving the gut microbiome has come to a convergent conclusion that commensal bacterium in the human body plays an undeniably important role in host physiological functions. They are involved in metabolizing foods, which allows the body to reclaim nutrients that would otherwise be lost as SCFAs such as butyrate. The microbiota has also been shown to provide protection from many chronic diseases of the gut, and they truly deserve the nickname of friendly bacteria.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="COI-statement">
<p>
<bold>Disclosure</bold>
</p>
<p>The authors report no conflicts of interest in this work.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="b1-ceg-10-091">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lederberg</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McCray</surname>
<given-names>AT</given-names>
</name>
</person-group>
<comment>webpage on the Internet</comment>
<article-title>‘Ome sweet’ omics—a genealogical treasury of words</article-title>
<source/>Scientist
          <year>2001</year>
<volume>15</volume>
<fpage>8</fpage>
<comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.the-scientist.com/?articles.view/articleNo/13313/title/-Ome-Sweet--Omics---A-Genealogical-Treasury-of-Words/">http://www.the-scientist.com/?articles.view/articleNo/13313/title/-Ome-Sweet--Omics---A-Genealogical-Treasury-of-Words/</ext-link></comment>
<date-in-citation>Accessed September 19, 2016</date-in-citation>
</element-citation>
</ref>
<ref id="b2-ceg-10-091">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sze</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hogg</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Bacterial microbiome of lungs in COPD</article-title>
<source/>Int J Chron Obstruct Pulmon Dis
          <year>2014</year>
<volume>9</volume>
<issue>1</issue>
<fpage>229</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="pmid">24591822</pub-id>
</element-citation>
</ref>
<ref id="b3-ceg-10-091">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grice</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Segre</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>The human microbiome: our second genome</article-title>
<source/>Annu Rev Genomics Hum Genet
          <year>2012</year>
<volume>13</volume>
<fpage>151</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="pmid">22703178</pub-id>
</element-citation>
</ref>
<ref id="b4-ceg-10-091">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grice</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Segre</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>The skin microbiome</article-title>
<source/>Nat Rev Microbiol
          <year>2011</year>
<volume>9</volume>
<issue>4</issue>
<fpage>244</fpage>
<lpage>253</lpage>
<pub-id pub-id-type="pmid">21407241</pub-id>
</element-citation>
</ref>
<ref id="b5-ceg-10-091">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ursell</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Metcalf</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Parfrey</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Defining the human microbiome</article-title>
<source/>Nutr Rev
          <year>2012</year>
<volume>70</volume>
<issue>Suppl 1</issue>
<fpage>S38</fpage>
<lpage>S44</lpage>
<pub-id pub-id-type="pmid">22861806</pub-id>
</element-citation>
</ref>
<ref id="b6-ceg-10-091">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turnbaugh</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Hamady</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fraser-Liggett</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>JI</given-names>
</name>
</person-group>
<article-title>The human microbiome project</article-title>
<source/>Nature
          <year>2007</year>
<volume>449</volume>
<fpage>804</fpage>
<lpage>810</lpage>
<pub-id pub-id-type="pmid">17943116</pub-id>
</element-citation>
</ref>
<ref id="b7-ceg-10-091">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Savage</surname>
<given-names>DC</given-names>
</name>
</person-group>
<article-title>Microbial ecology of the gastrointestinal tract</article-title>
<source/>Annu Rev Microbiol
          <year>1977</year>
<volume>31</volume>
<fpage>107</fpage>
<lpage>133</lpage>
<pub-id pub-id-type="pmid">334036</pub-id>
</element-citation>
</ref>
<ref id="b8-ceg-10-091">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>NIH HMP Working Group</collab>
<name>
<surname>Peterson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Garges</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The NIH Human Microbiome Project</article-title>
<source/>Genome Res
          <year>2009</year>
<volume>19</volume>
<issue>12</issue>
<fpage>2317</fpage>
<lpage>2323</lpage>
<pub-id pub-id-type="pmid">19819907</pub-id>
</element-citation>
</ref>
<ref id="b9-ceg-10-091">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donohoe</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Garge</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon</article-title>
<source/>Cell Metab
          <year>2011</year>
<volume>13</volume>
<issue>5</issue>
<fpage>517</fpage>
<lpage>526</lpage>
<pub-id pub-id-type="pmid">21531334</pub-id>
</element-citation>
</ref>
<ref id="b10-ceg-10-091">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bianconi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Piovesan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Facchin</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An estimation of the number of cells in the human body</article-title>
<source/>Ann Hum Biol
          <year>2013</year>
<volume>40</volume>
<issue>6</issue>
<fpage>463</fpage>
<lpage>471</lpage>
<pub-id pub-id-type="pmid">23829164</pub-id>
</element-citation>
</ref>
<ref id="b11-ceg-10-091">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosner</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Ten times more microbial cells than body cells in humans?</article-title>
<source/>Microbe
          <year>2014</year>
<volume>9</volume>
<issue>2</issue>
<fpage>47</fpage>
</element-citation>
</ref>
<ref id="b12-ceg-10-091">
<label>12</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>Institute of Medicine (US) Forum on Microbial Threats</collab>
</person-group>
<source/>Microbial Evolution and Co-Adaptation: A Tribute to the Life and Scientific Legacies of Joshua Lederberg: workshop summary [webpage on the Internet]
          <publisher-loc>Washington, DC</publisher-loc>
<publisher-name>National Academies Press</publisher-name>
<year>2009</year>
<comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK45714/">http://www.ncbi.nlm.nih.gov/books/NBK45714/</ext-link></comment>
<date-in-citation>Accessed August 20, 2016</date-in-citation>
</element-citation>
</ref>
<ref id="b13-ceg-10-091">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cabral</surname>
<given-names>JPS</given-names>
</name>
</person-group>
<article-title>Water microbiology. Bacterial pathogens and water</article-title>
<source/>Int J Environ Res Public Health
          <year>2010</year>
<volume>7</volume>
<issue>10</issue>
<fpage>3657</fpage>
<lpage>3703</lpage>
<pub-id pub-id-type="pmid">21139855</pub-id>
</element-citation>
</ref>
<ref id="b14-ceg-10-091">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saxena</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bharagava</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Kaithwas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Raj</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Microbial indicators, pathogens and methods for their monitoring in water environment</article-title>
<source/>J Water Health
          <year>2015</year>
<volume>13</volume>
<issue>2</issue>
<fpage>319</fpage>
<lpage>339</lpage>
<pub-id pub-id-type="pmid">26042966</pub-id>
</element-citation>
</ref>
<ref id="b15-ceg-10-091">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farooqui</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kazmi</surname>
<given-names>SU</given-names>
</name>
</person-group>
<article-title>Investigation of a community outbreak of typhoid fever associated with drinking water</article-title>
<source/>BMC Public Health
          <year>2009</year>
<volume>9</volume>
<fpage>476</fpage>
<pub-id pub-id-type="pmid">20021691</pub-id>
</element-citation>
</ref>
<ref id="b16-ceg-10-091">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sartelli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Ruppé</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<source/>World J Emerg Surg
          <year>2016</year>
<volume>11</volume>
<fpage>33</fpage>
<pub-id pub-id-type="pmid">27429642</pub-id>
</element-citation>
</ref>
<ref id="b17-ceg-10-091">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haque</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>NIA</given-names>
</name>
<name>
<surname>Zulkifli</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ismail</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Antibiotic prescribing and resistance: knowledge level of medical students of clinical years of University Sultan Zainal Abidin, Malaysia</article-title>
<source/>Ther Clin Risk Manag
          <year>2016</year>
<volume>12</volume>
<fpage>413</fpage>
<lpage>426</lpage>
<pub-id pub-id-type="pmid">27042083</pub-id>
</element-citation>
</ref>
<ref id="b18-ceg-10-091">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoque</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mostafa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Haque</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Intern doctors’ views on the current and future antibiotic resistance situation of Chattagram Maa O Shishu Hospital Medical College, Bangladesh</article-title>
<source/>Ther Clin Risk Manag
          <year>2015</year>
<volume>11</volume>
<fpage>1177</fpage>
<lpage>1185</lpage>
<pub-id pub-id-type="pmid">26316762</pub-id>
</element-citation>
</ref>
<ref id="b19-ceg-10-091">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoque</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mostafa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Haque</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Insight of medical students of clinical years to antimicrobials prescribing and resistance in private medical school, Chittagong, Bangladesh</article-title>
<source/>J Young Pharm
          <year>2016</year>
<volume>8</volume>
<issue>4</issue>
<fpage>447</fpage>
<lpage>455</lpage>
</element-citation>
</ref>
<ref id="b20-ceg-10-091">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>DK</given-names>
</name>
</person-group>
<article-title>Beneficial effects of human viruses</article-title>
<source/>Yale J Biol Med
          <year>1981</year>
<volume>54</volume>
<issue>1</issue>
<fpage>57</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="pmid">6264697</pub-id>
</element-citation>
</ref>
<ref id="b21-ceg-10-091">
<label>21</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Bryce</surname>
<given-names>K</given-names>
</name>
</person-group>
<source/>Fungi: Ecological Importance and Impact on Humans
          <publisher-loc>Chichester</publisher-loc>
<publisher-name>John Wiley &amp; Sons Ltd</publisher-name>
<year>2011</year>
</element-citation>
</ref>
<ref id="b22-ceg-10-091">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Relman</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Falkow</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>The meaning and impact of the human genome sequence for microbiology</article-title>
<source/>Trends Microbiol
          <year>2001</year>
<volume>9</volume>
<fpage>206</fpage>
<lpage>208</lpage>
<pub-id pub-id-type="pmid">11336835</pub-id>
</element-citation>
</ref>
<ref id="b23-ceg-10-091">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Relman</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>New technologies, human–microbe interactions, and the search for previously unrecognized pathogens</article-title>
<source/>J Infect Dis
          <year>2002</year>
<volume>186</volume>
<fpage>S254</fpage>
<lpage>S258</lpage>
<pub-id pub-id-type="pmid">12424706</pub-id>
</element-citation>
</ref>
<ref id="b24-ceg-10-091">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baugh</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Baugh</surname>
<given-names>AD</given-names>
</name>
</person-group>
<article-title>Infection, causation and indigenous flora</article-title>
<source/>J Aller Ther
          <year>2012</year>
<volume>3</volume>
<fpage>e104</fpage>
</element-citation>
</ref>
<ref id="b25-ceg-10-091">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sekirov</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Finlay</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Human and microbe: united we stand</article-title>
<source/>Nat Med
          <year>2006</year>
<volume>12</volume>
<issue>7</issue>
<fpage>736</fpage>
<lpage>737</lpage>
<pub-id pub-id-type="pmid">16829917</pub-id>
</element-citation>
</ref>
<ref id="b26-ceg-10-091">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phillips</surname>
<given-names>ML</given-names>
</name>
</person-group>
<article-title>Gut reaction: environmental effects on the human micro-biota</article-title>
<source/>Environ Health Perspect
          <year>2009</year>
<volume>117</volume>
<issue>5</issue>
<fpage>A198</fpage>
<lpage>A205</lpage>
<pub-id pub-id-type="pmid">19478986</pub-id>
</element-citation>
</ref>
<ref id="b27-ceg-10-091">
<label>27</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>Institute of Medicine (US) Food Forum</collab>
</person-group>
<source/>The Human Microbiome, Diet, and Health: workshop summary [webpage on the Internet]
          <publisher-loc>Washington (DC)</publisher-loc>
<publisher-name>National Academies Press</publisher-name>
<year>2013</year>
<comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK154093/">http://www.ncbi.nlm.nih.gov/books/NBK154093/</ext-link></comment>
<date-in-citation>Accessed September 21, 2016</date-in-citation>
</element-citation>
</ref>
<ref id="b28-ceg-10-091">
<label>28</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>Institute of Medicine (US) Forum on Microbial Threats</collab>
</person-group>
<source/>Ending the War Metaphor: The Changing Agenda for Unraveling the Host-Microbe Relationship: workshop summary [webpage on the Internet]
          <publisher-loc>Washington (DC)</publisher-loc>
<publisher-name>National Academies Press</publisher-name>
<year>2006</year>
<comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK57060/">http://www.ncbi.nlm.nih.gov/books/NBK57060/</ext-link></comment>
<date-in-citation>Accessed September 21, 2016</date-in-citation>
</element-citation>
</ref>
<ref id="b29-ceg-10-091">
<label>29</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>Forum on Microbial Health</collab>
<collab>Board on Global Health</collab>
<collab>Institute of Medicine</collab>
</person-group>
<source/>Microbial Ecology in States of Health and Disease: workshop summary [webpage on the Internet]
          <publisher-loc>Washington (DC)</publisher-loc>
<publisher-name>National Academies Press</publisher-name>
<year>2014</year>
<comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK189983/">http://www.ncbi.nlm.nih.gov/books/NBK189983/</ext-link></comment>
<date-in-citation>Accessed September 21, 2016</date-in-citation>
</element-citation>
</ref>
<ref id="b30-ceg-10-091">
<label>30</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>Institute of Medicine (US) Forum on Microbial Threats</collab>
</person-group>
<source/>The Social Biology of Microbial Communities: workshop summary [webpage on the Internet]
          <publisher-loc>Washington (DC)</publisher-loc>
<publisher-name>National Academies Press</publisher-name>
<year>2012</year>
<comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK154544/">http://www.ncbi.nlm.nih.gov/books/NBK154544/</ext-link></comment>
<date-in-citation>Accessed September 21, 2016</date-in-citation>
</element-citation>
</ref>
<ref id="b31-ceg-10-091">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wexler</surname>
<given-names>HM</given-names>
</name>
</person-group>
<article-title>Bacteroides: the good, the bad, and the nitty-gritty</article-title>
<source/>Clin Microbiol Rev
          <year>2007</year>
<volume>20</volume>
<issue>4</issue>
<fpage>593</fpage>
<lpage>621</lpage>
<pub-id pub-id-type="pmid">17934076</pub-id>
</element-citation>
</ref>
<ref id="b32-ceg-10-091">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ji</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>New insight into the gut microbiome through metagenomics</article-title>
<source/>Adv Genomics Genet
          <year>2015</year>
<volume>5</volume>
<fpage>77</fpage>
<lpage>91</lpage>
</element-citation>
</ref>
<ref id="b33-ceg-10-091">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakhtiar</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>LeBlanc</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Salvucci</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Implications of the human microbiome in Inflammatory Bowel Diseases</article-title>
<source/>FEMS Microbiol Lett
          <year>2013</year>
<volume>342</volume>
<issue>1</issue>
<fpage>10</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="pmid">23431991</pub-id>
</element-citation>
</ref>
<ref id="b34-ceg-10-091">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jandhyala</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Talukdar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Subramanyam</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vuyyuru</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sasikala</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>DN</given-names>
</name>
</person-group>
<article-title>Role of the normal gut microbiota</article-title>
<source/>World J Gastroenterol
          <year>2015</year>
<volume>21</volume>
<issue>29</issue>
<fpage>8787</fpage>
<lpage>8803</lpage>
<pub-id pub-id-type="pmid">26269668</pub-id>
</element-citation>
</ref>
<ref id="b35-ceg-10-091">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belkaid</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hand</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Role of the microbiota in immunity and inflammation</article-title>
<source/>Cell
          <year>2014</year>
<volume>157</volume>
<issue>1</issue>
<fpage>121</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="pmid">24679531</pub-id>
</element-citation>
</ref>
<ref id="b36-ceg-10-091">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langdon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Crook</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Dantas</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation</article-title>
<source/>Genome Med
          <year>2016</year>
<volume>8</volume>
<fpage>39</fpage>
<pub-id pub-id-type="pmid">27074706</pub-id>
</element-citation>
</ref>
<ref id="b37-ceg-10-091">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guinane</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Cotter</surname>
<given-names>PD</given-names>
</name>
</person-group>
<article-title>Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ</article-title>
<source/>Therap Adv Gastroenterol
          <year>2013</year>
<volume>6</volume>
<issue>4</issue>
<fpage>295</fpage>
<lpage>308</lpage>
</element-citation>
</ref>
<ref id="b38-ceg-10-091">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ettinger</surname>
<given-names>G</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Burton</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>The influence of the human microbiome and probiotics on cardiovascular health</article-title>
<source/>Gut Microbes
          <year>2014</year>
<volume>5</volume>
<issue>6</issue>
<fpage>719</fpage>
<lpage>728</lpage>
<pub-id pub-id-type="pmid">25529048</pub-id>
</element-citation>
</ref>
<ref id="b39-ceg-10-091">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winglee</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fodor</surname>
<given-names>AA</given-names>
</name>
</person-group>
<article-title>Intrinsic association between diet and the gut microbiome: current evidence</article-title>
<source/>Nutr Diet Suppl
          <year>2015</year>
<volume>7</volume>
<fpage>69</fpage>
<lpage>76</lpage>
</element-citation>
</ref>
<ref id="b40-ceg-10-091">
<label>40</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>CP</given-names>
</name>
</person-group>
<article-title>Chapter 6: Normal flora [webpage on the Internet]</article-title>
<person-group person-group-type="editor">
<name>
<surname>Baron</surname>
<given-names>S</given-names>
</name>
</person-group>
<source/>Medical Microbiology
          <edition>4th ed</edition>
<publisher-loc>Galveston (TX)</publisher-loc>
<publisher-name>University of Texas Medical Branch at Galveston</publisher-name>
<year>1996</year>
<comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK7617/">https://www.ncbi.nlm.nih.gov/books/NBK7617/</ext-link></comment>
<date-in-citation>Accessed October 16, 2016</date-in-citation>
</element-citation>
</ref>
<ref id="b41-ceg-10-091">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macfarlane</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Macfarlane</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Bacteria, colonic fermentation, and gastrointestinal health</article-title>
<source/>J AOAC Int
          <year>2012</year>
<volume>95</volume>
<issue>1</issue>
<fpage>50</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="pmid">22468341</pub-id>
</element-citation>
</ref>
<ref id="b42-ceg-10-091">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macfarlane</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hopkins</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Macfarlane</surname>
<given-names>GT</given-names>
</name>
</person-group>
<article-title>Bacterial growth and metabolism on surfaces in the large intestine</article-title>
<source/>Microb Ecol Health Dis
          <year>2000</year>
<volume>2</volume>
<fpage>64</fpage>
<lpage>72</lpage>
</element-citation>
</ref>
<ref id="b43-ceg-10-091">
<label>43</label>
<element-citation publication-type="webpage">
<person-group person-group-type="author">
<collab>Gut microbiota for health</collab>
</person-group>
<source/>Gut microbiota info [webpage on the Internet]
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.gutmicrobiotaforhealth.com/en/about-gut-microbiota-info/">http://www.gutmicrobiotaforhealth.com/en/about-gut-microbiota-info/</ext-link></comment>
<date-in-citation>Accessed February 27, 2017</date-in-citation>
</element-citation>
</ref>
<ref id="b44-ceg-10-091">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Waaij</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Harmsen</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Madjipour</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: commensal bacteria live in suspension and have no direct contact with epithelial cells</article-title>
<source/>Inflamm Bowel Dis
          <year>2005</year>
<volume>11</volume>
<fpage>865</fpage>
<lpage>871</lpage>
<pub-id pub-id-type="pmid">16189415</pub-id>
</element-citation>
</ref>
<ref id="b45-ceg-10-091">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marchesi</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Human distal gut microbiome</article-title>
<source/>Environ Microbiol
          <year>2011</year>
<volume>13</volume>
<issue>12</issue>
<fpage>3088</fpage>
<lpage>3102</lpage>
<pub-id pub-id-type="pmid">21906225</pub-id>
</element-citation>
</ref>
<ref id="b46-ceg-10-091">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macfarlane</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Macfarlane</surname>
<given-names>GT</given-names>
</name>
</person-group>
<article-title>Regulation of short-chain fatty acid production</article-title>
<source/>Proc Nutr Soc
          <year>2003</year>
<volume>62</volume>
<fpage>67</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="pmid">12740060</pub-id>
</element-citation>
</ref>
<ref id="b47-ceg-10-091">
<label>47</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>Institute of Medicine</collab>
</person-group>
<source/>Dietary, functional, and total fiber dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids [webpage on the Internet]
          <publisher-loc>Washington, DC</publisher-loc>
<publisher-name>The National Academic Press</publisher-name>
<year>2005</year>
<comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://fnic.nal.usda.gov/sites/fnic.nal.usda.gov/files/uploads/energy_full_report.pdf">https://fnic.nal.usda.gov/sites/fnic.nal.usda.gov/files/uploads/energy_full_report.pdf</ext-link></comment>
<date-in-citation>Accessed August 31, 2016</date-in-citation>
</element-citation>
</ref>
<ref id="b48-ceg-10-091">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cummings</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Short chain fatty acids in the human colon</article-title>
<source/>Gut
          <year>1981</year>
<volume>22</volume>
<issue>9</issue>
<fpage>763</fpage>
<lpage>779</lpage>
<pub-id pub-id-type="pmid">7028579</pub-id>
</element-citation>
</ref>
<ref id="b49-ceg-10-091">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hijova</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Chmelarova</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Short chain fatty acids and colonic health</article-title>
<source/>Bratisl Lek Listy
          <year>2007</year>
<volume>108</volume>
<issue>8</issue>
<fpage>354</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="pmid">18203540</pub-id>
</element-citation>
</ref>
<ref id="b50-ceg-10-091">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cummings</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Macfarlane</surname>
<given-names>GT</given-names>
</name>
</person-group>
<article-title>The control and consequences of bacterial fermentation in the human colon</article-title>
<source/>J Appl Bacteriol
          <year>1991</year>
<volume>70</volume>
<issue>6</issue>
<fpage>443</fpage>
<lpage>459</lpage>
<pub-id pub-id-type="pmid">1938669</pub-id>
</element-citation>
</ref>
<ref id="b51-ceg-10-091">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kundu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Viollet</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>KL</given-names>
</name>
</person-group>
<article-title>AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1</article-title>
<source/>Nat Cell Biol
          <year>2001</year>
<volume>13</volume>
<issue>2</issue>
<fpage>132</fpage>
<lpage>141</lpage>
</element-citation>
</ref>
<ref id="b52-ceg-10-091">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turnbaugh</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Ridaura</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Faith</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Rey</surname>
<given-names>FE</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>JI</given-names>
</name>
</person-group>
<article-title>The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice</article-title>
<source/>Sci Transl Med
          <year>2009</year>
<volume>1</volume>
<issue>6</issue>
<fpage>1</fpage>
<lpage>19</lpage>
</element-citation>
</ref>
<ref id="b53-ceg-10-091">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morrison</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Preston</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism</article-title>
<source/>Gut Microbes
          <year>2016</year>
<volume>7</volume>
<issue>3</issue>
<fpage>189</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="pmid">26963409</pub-id>
</element-citation>
</ref>
<ref id="b54-ceg-10-091">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>PV</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Offermanns</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Medzhitov</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2014</year>
<volume>111</volume>
<issue>6</issue>
<fpage>2247</fpage>
<lpage>2252</lpage>
<pub-id pub-id-type="pmid">24390544</pub-id>
</element-citation>
</ref>
<ref id="b55-ceg-10-091">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nastasi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Candela</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bonefeld</surname>
<given-names>CM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The effect of short-chain fatty acids on human monocyte-derived dendritic cells</article-title>
<source/>Sci Rep
          <year>2015</year>
<volume>5</volume>
<fpage>16148</fpage>
<pub-id pub-id-type="pmid">26541096</pub-id>
</element-citation>
</ref>
<ref id="b56-ceg-10-091">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vernia</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fracasso</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Casale</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Topical butyrate for acute radiation proctitis: randomized, crossover trial</article-title>
<source/>Lancet
          <year>2000</year>
<volume>356</volume>
<issue>9237</issue>
<fpage>1232</fpage>
<lpage>1235</lpage>
<pub-id pub-id-type="pmid">11072942</pub-id>
</element-citation>
</ref>
<ref id="b57-ceg-10-091">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vernia</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Annese</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bresci</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicenter trial</article-title>
<source/>Eur J Clin Invest
          <year>2003</year>
<volume>33</volume>
<issue>3</issue>
<fpage>244</fpage>
<lpage>248</lpage>
<pub-id pub-id-type="pmid">12641543</pub-id>
</element-citation>
</ref>
<ref id="b58-ceg-10-091">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cox</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stanton</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Short-chain fatty acids act as anti-inflammatory mediators by regulating prostaglandin E2 and cytokines</article-title>
<source/>World J Gastroenterol
          <year>2009</year>
<volume>15</volume>
<issue>44</issue>
<fpage>5549</fpage>
<lpage>5557</lpage>
<pub-id pub-id-type="pmid">19938193</pub-id>
</element-citation>
</ref>
<ref id="b59-ceg-10-091">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deshmane</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Kremlev</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Amini</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sawaya</surname>
<given-names>BE</given-names>
</name>
</person-group>
<article-title>Monocyte chemoattractant protein-1 (MCP-1): an overview</article-title>
<source/>J Interferon Cytokine Res
          <year>2009</year>
<volume>29</volume>
<issue>6</issue>
<fpage>313</fpage>
<lpage>326</lpage>
<pub-id pub-id-type="pmid">19441883</pub-id>
</element-citation>
</ref>
<ref id="b60-ceg-10-091">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bindels</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Porporato</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dewulf</surname>
<given-names>EM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota-derived propionate reduces cancer cell proliferation in the liver</article-title>
<source/>Br J Cancer
          <year>2012</year>
<volume>107</volume>
<issue>8</issue>
<fpage>1337</fpage>
<lpage>1344</lpage>
<pub-id pub-id-type="pmid">22976799</pub-id>
</element-citation>
</ref>
<ref id="b61-ceg-10-091">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lupton</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Diet induced changes in the colonic environment and colorectal cancer. Microbial degradation products influence colon cancer risk: the butyrate controversy</article-title>
<source/>J Nutr
          <year>2004</year>
<volume>134</volume>
<issue>2</issue>
<fpage>479</fpage>
<lpage>482</lpage>
<pub-id pub-id-type="pmid">14747692</pub-id>
</element-citation>
</ref>
<ref id="b62-ceg-10-091">
<label>62</label>
<mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>Food Quality and Standards Service (AGNS)</collab></person-group> Food and Agriculture Organization of the <source/>United Nations (FAO). FAO Technical Meeting on Prebiotics [webpage on the Internet]<year>2007</year><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=2&amp;cad=rja&amp;uact=8&amp;ved=0ahUKEwiu_4CohOvOAhWKqo8KHSjyCZEQFggtMAE&amp;url=http&amp;percnt;3A%2F%2Fwww.aat-taa.eu%2Findex%2Fen%2Fcompany%2Fdownload%2F1262610500.html&amp;usg=AFQjCNHQcmt3Yr7aVimPbXm-lNpO-UNK8Q&amp;sig2=EpOjN3rnHZ2JJKPkPO6uVQ">https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=2&amp;cad=rja&amp;uact=8&amp;ved=0ahUKEwiu_4CohOvOAhWKqo8KHSjyCZEQFggtMAE&amp;url=http&amp;percnt;3A%2F%2Fwww.aat-taa.eu%2Findex%2Fen%2Fcompany%2Fdownload%2F1262610500.html&amp;usg=AFQjCNHQcmt3Yr7aVimPbXm-lNpO-UNK8Q&amp;sig2=EpOjN3rnHZ2JJKPkPO6uVQ</ext-link></comment><date-in-citation>Accessed August 31, 2016</date-in-citation></mixed-citation>
</ref>
<ref id="b63-ceg-10-091">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pineiro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Asp</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<source/>J Clin Gastroenterol
          <year>2008</year>
<volume>42</volume>
<issue>Suppl 3; Pt 2</issue>
<fpage>S156</fpage>
<lpage>S159</lpage>
<pub-id pub-id-type="pmid">18685504</pub-id>
</element-citation>
</ref>
<ref id="b64-ceg-10-091">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macfarlane</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Macfarlane</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Cummings</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Review article prebiotics in the gastrointestinal tract</article-title>
<source/>Aliment Pharmacol Ther
          <year>2006</year>
<volume>24</volume>
<issue>5</issue>
<fpage>701</fpage>
<lpage>714</lpage>
<pub-id pub-id-type="pmid">16918875</pub-id>
</element-citation>
</ref>
<ref id="b65-ceg-10-091">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macfarlane</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Steed</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Macfarlane</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics</article-title>
<source/>J Appl Microbiol
          <year>2008</year>
<volume>104</volume>
<issue>2</issue>
<fpage>305</fpage>
<lpage>344</lpage>
<pub-id pub-id-type="pmid">18215222</pub-id>
</element-citation>
</ref>
<ref id="b66-ceg-10-091">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Felis</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Dellaglio</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Taxonomy of lactobacilli and bifidobacteria</article-title>
<source/>Curr Issues Intest Microbiol
          <year>2007</year>
<volume>8</volume>
<issue>2</issue>
<fpage>44</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="pmid">17542335</pub-id>
</element-citation>
</ref>
<ref id="b67-ceg-10-091">
<label>67</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Macfarlane</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Macfarlane</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Manipulating the indigenous microbiota in humans- prebiotics, probiotics and symbiotics</article-title>
<person-group person-group-type="editor">
<name>
<surname>Fredricks</surname>
<given-names>DN</given-names>
</name>
</person-group>
<source/>The Human Microbiota: How Microbial Communities Affect Health and Disease
          <publisher-loc>Hoboken, NJ</publisher-loc>
<publisher-name>John Wiley &amp; Sons Inc</publisher-name>
<year>2013</year>
<fpage>315</fpage>
<lpage>334</lpage>
</element-citation>
</ref>
<ref id="b68-ceg-10-091">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manning</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>GR</given-names>
</name>
</person-group>
<article-title>Prebiotics</article-title>
<source/>Best Pract Res Clin Gastroenterol
          <year>2004</year>
<volume>18</volume>
<issue>2</issue>
<fpage>287</fpage>
<lpage>298</lpage>
<pub-id pub-id-type="pmid">15123070</pub-id>
</element-citation>
</ref>
<ref id="b69-ceg-10-091">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vyas</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Ranganathan</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Probiotics, prebiotics, and symbiotics: gut and beyond</article-title>
<source/>Gastroenterol Res Pract
          <year>2012</year>
<volume>1</volume>
<issue>2012</issue>
<fpage>1</fpage>
<lpage>16</lpage>
</element-citation>
</ref>
<ref id="b70-ceg-10-091">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Balciunas</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Converti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cotter</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Pinheiro</surname>
<given-names>R</given-names>
</name>
<name>
<surname>de Souza Oliveira</surname>
<given-names>RP</given-names>
</name>
</person-group>
<article-title>Bacteriocin production by Bifidobacterium spp. A review</article-title>
<source/>Biotechnol Adv
          <year>2013</year>
<volume>31</volume>
<issue>4</issue>
<fpage>482</fpage>
<lpage>488</lpage>
<pub-id pub-id-type="pmid">23384878</pub-id>
</element-citation>
</ref>
<ref id="b71-ceg-10-091">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DiRienzo</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Effect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy diets</article-title>
<source/>Nutr Rev
          <year>2014</year>
<volume>72</volume>
<issue>1</issue>
<fpage>18</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="pmid">24330093</pub-id>
</element-citation>
</ref>
<ref id="b72-ceg-10-091">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilbert</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Krajmalnik-Brown</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Porazinska</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Toward effective probiotics for autism and other neurodevelopmental disorders</article-title>
<source/>Cell
          <year>2013</year>
<volume>155</volume>
<issue>7</issue>
<fpage>1446</fpage>
<lpage>1448</lpage>
<pub-id pub-id-type="pmid">24360269</pub-id>
</element-citation>
</ref>
<ref id="b73-ceg-10-091">
<label>73</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Martoni</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Prakash</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial</article-title>
<source/>J Clin Endocrinol Metab
          <year>2013</year>
<volume>98</volume>
<issue>7</issue>
<fpage>2944</fpage>
<lpage>2951</lpage>
<pub-id pub-id-type="pmid">23609838</pub-id>
</element-citation>
</ref>
<ref id="b74-ceg-10-091">
<label>74</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Baek</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>BH</given-names>
</name>
</person-group>
<article-title>Probiotics and prebiotics as bioactive components in dairy products</article-title>
<person-group person-group-type="editor">
<name>
<surname>Park</surname>
<given-names>YW</given-names>
</name>
</person-group>
<source/>Bioactive Components in Milk Dairy Products
          <publisher-loc>New York</publisher-loc>
<publisher-name>Wiley-Blackwell</publisher-name>
<year>2009</year>
</element-citation>
</ref>
<ref id="b75-ceg-10-091">
<label>75</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daliri</surname>
<given-names>EBM</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>BH</given-names>
</name>
</person-group>
<article-title>New perspectives on probiotics in health and disease</article-title>
<source/>Food Sci Hum Wellness
          <year>2015</year>
<volume>4</volume>
<issue>2</issue>
<fpage>56</fpage>
<lpage>65</lpage>
</element-citation>
</ref>
<ref id="b76-ceg-10-091">
<label>76</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McAuliffe</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Cano</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Klaenhammer</surname>
<given-names>TR</given-names>
</name>
</person-group>
<article-title>Genetic analysis of two bile salt hydrolase activities in Lactobacillus acidophilus NCFM</article-title>
<source/>Appl Environ Microbiol
          <year>2005</year>
<volume>71</volume>
<issue>8</issue>
<fpage>4925</fpage>
<lpage>4929</lpage>
<pub-id pub-id-type="pmid">16085898</pub-id>
</element-citation>
</ref>
<ref id="b77-ceg-10-091">
<label>77</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishimwe</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Daliri</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>The perspective on cholesterol-lowering mechanisms of probiotics</article-title>
<source/>Mol Nutr Food Res
          <year>2015</year>
<volume>59</volume>
<issue>1</issue>
<fpage>94</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="pmid">25403164</pub-id>
</element-citation>
</ref>
<ref id="b78-ceg-10-091">
<label>78</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ooi</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Liong</surname>
<given-names>MT</given-names>
</name>
</person-group>
<article-title>Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings</article-title>
<source/>Int J Mol Sci
          <year>2010</year>
<volume>11</volume>
<issue>6</issue>
<fpage>2499</fpage>
<lpage>2522</lpage>
<pub-id pub-id-type="pmid">20640165</pub-id>
</element-citation>
</ref>
<ref id="b79-ceg-10-091">
<label>79</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waigankar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Role of probiotics in urogenital healthcare</article-title>
<source/>J Midlife Health
          <year>2011</year>
<volume>2</volume>
<issue>1</issue>
<fpage>5</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="pmid">21897732</pub-id>
</element-citation>
</ref>
<ref id="b80-ceg-10-091">
<label>80</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banas</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Popp</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Recovery of viable bacteria from probiotic products that target oral health</article-title>
<source/>Probiotics Antimicrob Proteins
          <year>2013</year>
<volume>5</volume>
<issue>3</issue>
<fpage>227</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="pmid">24015157</pub-id>
</element-citation>
</ref>
<ref id="b81-ceg-10-091">
<label>81</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loesche</surname>
<given-names>WJ</given-names>
</name>
</person-group>
<article-title>Role of Streptococcus mutans in human dental decay</article-title>
<source/>Microbiol Rev
          <year>1986</year>
<volume>50</volume>
<issue>4</issue>
<fpage>353</fpage>
<lpage>380</lpage>
<pub-id pub-id-type="pmid">3540569</pub-id>
</element-citation>
</ref>
<ref id="b82-ceg-10-091">
<label>82</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anilkumar</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Monisha</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Role of friendly bacteria in oral health – a short review</article-title>
<source/>Oral Health Prev Dent
          <year>2012</year>
<volume>10</volume>
<issue>1</issue>
<fpage>3</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">22908082</pub-id>
</element-citation>
</ref>
<ref id="b83-ceg-10-091">
<label>83</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bizzini</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pizzo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Scapagnini</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nuzzo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Vasto</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Probiotics and oral health</article-title>
<source/>Curr Pharm Des
          <year>2012</year>
<volume>18</volume>
<issue>34</issue>
<fpage>5522</fpage>
<lpage>5531</lpage>
<pub-id pub-id-type="pmid">22632388</pub-id>
</element-citation>
</ref>
<ref id="b84-ceg-10-091">
<label>84</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haukioja</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Probiotics and oral health</article-title>
<source/>Eur J Dent
          <year>2010</year>
<volume>4</volume>
<issue>3</issue>
<fpage>348</fpage>
<lpage>355</lpage>
<pub-id pub-id-type="pmid">20613927</pub-id>
</element-citation>
</ref>
<ref id="b85-ceg-10-091">
<label>85</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Pierro</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Adami</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rapacioli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Giardini</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Streitberger</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults</article-title>
<source/>Expert Opin Biol Ther
          <year>2013</year>
<volume>13</volume>
<issue>3</issue>
<fpage>339</fpage>
<lpage>343</lpage>
<pub-id pub-id-type="pmid">23286823</pub-id>
</element-citation>
</ref>
<ref id="b86-ceg-10-091">
<label>86</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Pierro</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Colombo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zanvit</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Risso</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rottoli</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in children</article-title>
<source/>Drug Healthc Patient Saf
          <year>2014</year>
<volume>6</volume>
<fpage>15</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="pmid">24600248</pub-id>
</element-citation>
</ref>
<ref id="b87-ceg-10-091">
<label>87</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ibrahim</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>O’Sullivan</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>Use of chemical mutagenesis for the isolation of food grade β-galactosidase overproducing mutants of bifidobacteria, lactobacilli and Streptococcus thermophilus</article-title>
<source/>J Dairy Sci
          <year>2000</year>
<volume>83</volume>
<issue>5</issue>
<fpage>923</fpage>
<lpage>930</lpage>
<pub-id pub-id-type="pmid">10821566</pub-id>
</element-citation>
</ref>
<ref id="b88-ceg-10-091">
<label>88</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van den Bogaard</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Kleerebezem</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kuipers</surname>
<given-names>OP</given-names>
</name>
<name>
<surname>de Vos</surname>
<given-names>WM</given-names>
</name>
</person-group>
<article-title>Control of lactose transport, β-galactosidase activity, and glycolysis by CcpA in Streptococcus thermophilus: evidence for carbon catabolite repression by a non-phosphoenolpyruvate-dependent phosphotransferase system sugar</article-title>
<source/>J Bacteriol
          <year>2000</year>
<volume>182</volume>
<issue>21</issue>
<fpage>5982</fpage>
<lpage>5989</lpage>
<pub-id pub-id-type="pmid">11029416</pub-id>
</element-citation>
</ref>
<ref id="b89-ceg-10-091">
<label>89</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goh</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Klaenhammer</surname>
<given-names>TR</given-names>
</name>
</person-group>
<article-title>A functional glycogen biosynthesis pathway in Lactobacillus acidophilus: expression and analysis of the glgoperon</article-title>
<source/>Mol Microbiol
          <year>2013</year>
<volume>89</volume>
<issue>6</issue>
<fpage>1187</fpage>
<lpage>1200</lpage>
<pub-id pub-id-type="pmid">23879596</pub-id>
</element-citation>
</ref>
<ref id="b90-ceg-10-091">
<label>90</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foxx-Orenstein</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Chey</surname>
<given-names>WD</given-names>
</name>
</person-group>
<article-title>Manipulation of the gut microbiota as a novel treatment strategy for gastrointestinal disorders</article-title>
<source/>Am J Gastroenterol
          <year>2012</year>
<volume>1</volume>
<fpage>41</fpage>
<lpage>46</lpage>
</element-citation>
</ref>
<ref id="b91-ceg-10-091">
<label>91</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Zanten</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Knudsen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Röytiö</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The effect of selected symbiotics on microbial composition and short-chain fatty acid production in a model system of the human colon</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<issue>10</issue>
<fpage>e47212</fpage>
<pub-id pub-id-type="pmid">23082149</pub-id>
</element-citation>
</ref>
<ref id="b92-ceg-10-091">
<label>92</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furrie</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Macfarlane</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Symbiotic therapy (Bifidobacteria longum/synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis</article-title>
<source/>Gut
          <year>2005</year>
<volume>54</volume>
<issue>2</issue>
<fpage>242</fpage>
<lpage>249</lpage>
<pub-id pub-id-type="pmid">15647189</pub-id>
</element-citation>
</ref>
<ref id="b93-ceg-10-091">
<label>93</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miquel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Martín</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>O</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Faecalibacterium prausnitzii and human intestinal health</article-title>
<source/>Curr Opin Microbiol
          <year>2013</year>
<volume>16</volume>
<issue>3</issue>
<fpage>255</fpage>
<lpage>261</lpage>
<pub-id pub-id-type="pmid">23831042</pub-id>
</element-citation>
</ref>
<ref id="b94-ceg-10-091">
<label>94</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Symbiotic gut microbes modulate human metabolic phenotypes</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2008</year>
<volume>105</volume>
<issue>6</issue>
<fpage>2117</fpage>
<lpage>2122</lpage>
<pub-id pub-id-type="pmid">18252821</pub-id>
</element-citation>
</ref>
<ref id="b95-ceg-10-091">
<label>95</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foditsch</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>RV</given-names>
</name>
<name>
<surname>Ganda</surname>
<given-names>EK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oral administration of Faecalibacterium prausnitzii decreased the incidence of severe diarrhea and related mortality rate and increased weight gain in preweaned dairy heifers</article-title>
<source/>PLoS One
          <year>2015</year>
<volume>10</volume>
<issue>12</issue>
<fpage>e0145485</fpage>
<pub-id pub-id-type="pmid">26710101</pub-id>
</element-citation>
</ref>
<ref id="b96-ceg-10-091">
<label>96</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Round</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Mazmanian</surname>
<given-names>SK</given-names>
</name>
</person-group>
<article-title>The gut microbiome shapes intestinal immune responses during health and disease</article-title>
<source/>Nat Rev Immunol
          <year>2009</year>
<volume>9</volume>
<issue>5</issue>
<fpage>313</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="pmid">19343057</pub-id>
</element-citation>
</ref>
<ref id="b97-ceg-10-091">
<label>97</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Izcue</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hue</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Buonocore</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. T cells can induce colitis in IL-23 deficient recipients, suggesting that disease can result in the absence of regulation</article-title>
<source/>Immunity
          <year>2008</year>
<volume>28</volume>
<issue>4</issue>
<fpage>559</fpage>
<lpage>570</lpage>
<pub-id pub-id-type="pmid">18400195</pub-id>
</element-citation>
</ref>
<ref id="b98-ceg-10-091">
<label>98</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fallani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics</article-title>
<source/>J Pediatr Gastroenterol Nutr
          <year>2010</year>
<volume>51</volume>
<issue>1</issue>
<fpage>77</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="pmid">20479681</pub-id>
</element-citation>
</ref>
<ref id="b99-ceg-10-091">
<label>99</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>K</given-names>
</name>
<name>
<surname>DeCoffe</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Molcan</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>DL</given-names>
</name>
</person-group>
<article-title>Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease</article-title>
<source/>Nutrients
          <year>2012</year>
<volume>4</volume>
<issue>8</issue>
<fpage>1095</fpage>
<lpage>1119</lpage>
<pub-id pub-id-type="pmid">23016134</pub-id>
</element-citation>
</ref>
<ref id="b100-ceg-10-091">
<label>100</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cenit</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Olivares</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Codoñer-Franch</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Sanz</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Intestinal microbiota and celiac disease: cause, consequence or co-evolution?</article-title>
<source/>Nutrients
          <year>2015</year>
<volume>7</volume>
<issue>8</issue>
<fpage>6900</fpage>
<lpage>6923</lpage>
<pub-id pub-id-type="pmid">26287240</pub-id>
</element-citation>
</ref>
<ref id="b101-ceg-10-091">
<label>101</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collado</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Donat</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ribes-Koninckx</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Calabuig</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sanz</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease</article-title>
<source/>J Clin Pathol
          <year>2009</year>
<volume>62</volume>
<fpage>264</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="pmid">18996905</pub-id>
</element-citation>
</ref>
<ref id="b102-ceg-10-091">
<label>102</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collado</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Donat</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ribes-Koninckx</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Calabuig</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sanz</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease</article-title>
<source/>BMC Microbiol
          <year>2008</year>
<volume>8</volume>
<fpage>232</fpage>
<pub-id pub-id-type="pmid">19102766</pub-id>
</element-citation>
</ref>
<ref id="b103-ceg-10-091">
<label>103</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Cagno</surname>
<given-names>R</given-names>
</name>
<name>
<surname>De Angelis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>De Pasquale</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization</article-title>
<source/>BMC Microbiol
          <year>2011</year>
<volume>11</volume>
<fpage>219</fpage>
<pub-id pub-id-type="pmid">21970810</pub-id>
</element-citation>
</ref>
<ref id="b104-ceg-10-091">
<label>104</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nistal</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Caminero</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vivas</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differences in faecal bacteria populations and faecal bacteria metabolism in healthy adults and celiac disease patients</article-title>
<source/>Biochimie
          <year>2012</year>
<volume>94</volume>
<fpage>1724</fpage>
<lpage>1729</lpage>
<pub-id pub-id-type="pmid">22542995</pub-id>
</element-citation>
</ref>
<ref id="b105-ceg-10-091">
<label>105</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanz</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Effects of a gluten-free diet on gut microbiota and immune function in healthy adult humans</article-title>
<source/>Gut Microbes
          <year>2010</year>
<volume>1</volume>
<issue>3</issue>
<fpage>135</fpage>
<lpage>137</lpage>
<pub-id pub-id-type="pmid">21327021</pub-id>
</element-citation>
</ref>
<ref id="b106-ceg-10-091">
<label>106</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pacheco</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Barile</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Underwood</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Mills</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>The impact of the milk glycobiome on the neonate gut microbiota</article-title>
<source/>Annu Rev Anim Biosci
          <year>2015</year>
<volume>3</volume>
<fpage>419</fpage>
<lpage>445</lpage>
<pub-id pub-id-type="pmid">25387230</pub-id>
</element-citation>
</ref>
<ref id="b107-ceg-10-091">
<label>107</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arrieta</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Stiemsma</surname>
<given-names>LT</given-names>
</name>
<name>
<surname>Amenyogbe</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Finlay</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>The intestinal microbiome in early life: health and disease</article-title>
<source/>Front Immun
          <year>2014</year>
<volume>5</volume>
<fpage>427</fpage>
</element-citation>
</ref>
<ref id="b108-ceg-10-091">
<label>108</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Basile</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Ebeling</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>CL</given-names>
</name>
</person-group>
<article-title>Intestinal permeability in preterm infants by feeding type: mother’s milk versus formula</article-title>
<source/>Breastfeed Med
          <year>2009</year>
<volume>4</volume>
<issue>1</issue>
<fpage>11</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="pmid">19196035</pub-id>
</element-citation>
</ref>
<ref id="b109-ceg-10-091">
<label>109</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sekirov</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Caetano</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Antunes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Finlay</surname>
<given-names>BB</given-names>
</name>
</person-group>
<article-title>Gut microbiota in health and disease</article-title>
<source/>Am Physiol Soc
          <year>2010</year>
<volume>90</volume>
<fpage>859</fpage>
<lpage>904</lpage>
</element-citation>
</ref>
<ref id="b110-ceg-10-091">
<label>110</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conlon</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>AR</given-names>
</name>
</person-group>
<article-title>The impact of diet and lifestyle on gut microbiota and human health</article-title>
<source/>Nutrients
          <year>2015</year>
<volume>7</volume>
<issue>1</issue>
<fpage>17</fpage>
<lpage>44</lpage>
</element-citation>
</ref>
<ref id="b111-ceg-10-091">
<label>111</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Myles</surname>
<given-names>IA</given-names>
</name>
</person-group>
<article-title>Fast food fever: reviewing the impacts of the Western diet on immunity</article-title>
<source/>Nutr J
          <year>2014</year>
<volume>13</volume>
<fpage>61</fpage>
<pub-id pub-id-type="pmid">24939238</pub-id>
</element-citation>
</ref>
<ref id="b112-ceg-10-091">
<label>112</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Linking long-term dietary patterns with gut microbial enterotypes</article-title>
<source/>Science
          <year>2011</year>
<volume>334</volume>
<issue>6052</issue>
<fpage>105</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="pmid">21885731</pub-id>
</element-citation>
</ref>
<ref id="b113-ceg-10-091">
<label>113</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pendyala</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Holt</surname>
<given-names>PR</given-names>
</name>
</person-group>
<article-title>A high-fat diet is associated with endotoxemia that originates from the gut</article-title>
<source/>Gastroenterology
          <year>2012</year>
<volume>142</volume>
<issue>5</issue>
<fpage>1100</fpage>
<lpage>1101</lpage>
<pub-id pub-id-type="pmid">22326433</pub-id>
</element-citation>
</ref>
<ref id="b114-ceg-10-091">
<label>114</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dueñas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Muñoz-González</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Cueva</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A survey of modulation of gut microbiota by dietary polyphenols</article-title>
<source/>Biomed Res Int
          <year>2015</year>
<volume>2015</volume>
<fpage>850902</fpage>
<pub-id pub-id-type="pmid">25793210</pub-id>
</element-citation>
</ref>
<ref id="b115-ceg-10-091">
<label>115</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hullar</surname>
<given-names>MAJ</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>BC</given-names>
</name>
</person-group>
<article-title>Diet, the gut microbiome, and epigenetics</article-title>
<source/>Cancer J
          <year>2014</year>
<volume>20</volume>
<issue>3</issue>
<fpage>170</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="pmid">24855003</pub-id>
</element-citation>
</ref>
<ref id="b116-ceg-10-091">
<label>116</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Filippo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cavalieri</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Di Paola</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2010</year>
<volume>107</volume>
<issue>33</issue>
<fpage>14691</fpage>
<lpage>14696</lpage>
<pub-id pub-id-type="pmid">20679230</pub-id>
</element-citation>
</ref>
<ref id="b117-ceg-10-091">
<label>117</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yatsunenko</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rey</surname>
<given-names>FE</given-names>
</name>
<name>
<surname>Manary</surname>
<given-names>MJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human gut microbiome viewed across age and geography</article-title>
<source/>Nature
          <year>2012</year>
<volume>486</volume>
<issue>7402</issue>
<fpage>222</fpage>
<lpage>227</lpage>
<pub-id pub-id-type="pmid">22699611</pub-id>
</element-citation>
</ref>
<ref id="b118-ceg-10-091">
<label>118</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bik</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Costello</surname>
<given-names>EK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<issue>1</issue>
<fpage>e53838</fpage>
<pub-id pub-id-type="pmid">23349750</pub-id>
</element-citation>
</ref>
<ref id="b119-ceg-10-091">
<label>119</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laparra</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Sanz</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Interactions of gut microbiota with functional food components and nutraceuticals</article-title>
<source/>Pharmacol Res
          <year>2010</year>
<volume>61</volume>
<issue>3</issue>
<fpage>219</fpage>
<lpage>225</lpage>
<pub-id pub-id-type="pmid">19914380</pub-id>
</element-citation>
</ref>
<ref id="b120-ceg-10-091">
<label>120</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Marco</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Slupsky</surname>
<given-names>CM</given-names>
</name>
</person-group>
<article-title>Emerging aspects of food and nutrition on gut microbiota</article-title>
<source/>J Agric Food Chem
          <year>2013</year>
<volume>61</volume>
<issue>40</issue>
<fpage>9559</fpage>
<lpage>9574</lpage>
<pub-id pub-id-type="pmid">24028159</pub-id>
</element-citation>
</ref>
<ref id="b121-ceg-10-091">
<label>121</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hervert-Hernandez</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Goñi</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Dietary polyphenols and human gut microbiota: a review</article-title>
<source/>Food Rev Int
          <year>2011</year>
<volume>27</volume>
<issue>2</issue>
<fpage>154</fpage>
<lpage>169</lpage>
</element-citation>
</ref>
<ref id="b122-ceg-10-091">
<label>122</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tuohy</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Conterno</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gasperotti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Viola</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Upregulating the human intestinal microbiome using whole plant foods, polyphenols, and/or fiber</article-title>
<source/>J Agric Food Chem
          <year>2012</year>
<volume>60</volume>
<issue>36</issue>
<fpage>8776</fpage>
<lpage>8782</lpage>
<pub-id pub-id-type="pmid">22607578</pub-id>
</element-citation>
</ref>
<ref id="b123-ceg-10-091">
<label>123</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Etxeberria</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Fernández-Quintela</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Milagro</surname>
<given-names>FI</given-names>
</name>
<name>
<surname>Aguirre</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Martínez</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Portillo</surname>
<given-names>MP</given-names>
</name>
</person-group>
<article-title>Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition</article-title>
<source/>J Agric Food Chem
          <year>2013</year>
<volume>61</volume>
<issue>40</issue>
<fpage>9517</fpage>
<lpage>9533</lpage>
<pub-id pub-id-type="pmid">24033291</pub-id>
</element-citation>
</ref>
<ref id="b124-ceg-10-091">
<label>124</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cardona</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Andrés-Lacueva</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tulipani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tinahones</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Queipo-Ortuño</surname>
<given-names>MI</given-names>
</name>
</person-group>
<article-title>Benefits of polyphenols on gut microbiota and implications in human health</article-title>
<source/>J Nutr Biochem
          <year>2013</year>
<volume>24</volume>
<issue>8</issue>
<fpage>1415</fpage>
<lpage>1422</lpage>
<pub-id pub-id-type="pmid">23849454</pub-id>
</element-citation>
</ref>
<ref id="b125-ceg-10-091">
<label>125</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selma</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Espín</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Tomás-Barberán</surname>
<given-names>FA</given-names>
</name>
</person-group>
<article-title>Interaction between phenolics and gut microbiota: role in human health</article-title>
<source/>J Agric Food Chem
          <year>2009</year>
<volume>57</volume>
<issue>15</issue>
<fpage>6485</fpage>
<lpage>6501</lpage>
<pub-id pub-id-type="pmid">19580283</pub-id>
</element-citation>
</ref>
<ref id="b126-ceg-10-091">
<label>126</label>
<element-citation publication-type="webpage">
<person-group person-group-type="author">
<collab>Johns Hopkins Medicine</collab>
</person-group>
<source/>Gastroenterology and Hepatology. Fecal Transplantation (Bacteriotherapy)
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.hop-kinsmedicine.org/gastroenterology_hepatology/clinical_services/advanced_endoscopy/fecal_transplantation.html">http://www.hop-kinsmedicine.org/gastroenterology_hepatology/clinical_services/advanced_endoscopy/fecal_transplantation.html</ext-link></comment>
<date-in-citation>Accessed February 27, 2017</date-in-citation>
</element-citation>
</ref>
<ref id="b127-ceg-10-091">
<label>127</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakken</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Borody</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Brandt</surname>
<given-names>LJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Treating Clostridium difficile infection with fecal microbiota transplantation</article-title>
<source/>Clin Gastroenterol Hepatol
          <year>2011</year>
<volume>9</volume>
<issue>12</issue>
<fpage>1044</fpage>
<lpage>1049</lpage>
<pub-id pub-id-type="pmid">21871249</pub-id>
</element-citation>
</ref>
<ref id="b128-ceg-10-091">
<label>128</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kassam</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hunt</surname>
<given-names>RH</given-names>
</name>
</person-group>
<article-title>Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis</article-title>
<source/>Am J Gastroenterol
          <year>2013</year>
<volume>108</volume>
<issue>4</issue>
<fpage>500</fpage>
<lpage>508</lpage>
<pub-id pub-id-type="pmid">23511459</pub-id>
</element-citation>
</ref>
<ref id="b129-ceg-10-091">
<label>129</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borody</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Khoruts</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Fecal microbiota transplantation and emerging applications</article-title>
<source/>Nat Rev Gastroenterol Hepatol
          <year>2011</year>
<volume>9</volume>
<issue>2</issue>
<fpage>88</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="pmid">22183182</pub-id>
</element-citation>
</ref>
<ref id="b130-ceg-10-091">
<label>130</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loo</surname>
<given-names>VG</given-names>
</name>
<name>
<surname>Poirier</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality</article-title>
<source/>N Engl J Med
          <year>2005</year>
<volume>353</volume>
<issue>23</issue>
<fpage>2442</fpage>
<lpage>2449</lpage>
<pub-id pub-id-type="pmid">16322602</pub-id>
</element-citation>
</ref>
<ref id="b131-ceg-10-091">
<label>131</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vonberg</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Reichardt</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Behnke</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schwab</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zindler</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gastmeier</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Cost of nosocomial Clostridium difficile-associated diarrhea</article-title>
<source/>J Hosp Infect
          <year>2008</year>
<volume>70</volume>
<issue>1</issue>
<fpage>15</fpage>
<lpage>20</lpage>
</element-citation>
</ref>
<ref id="b132-ceg-10-091">
<label>132</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubberke</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Olsen</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Burden of Clostridium difficile on the healthcare system</article-title>
<source/>Clin Infect Dis
          <year>2012</year>
<volume>55</volume>
<issue>Suppl 2</issue>
<fpage>S88</fpage>
<lpage>S92</lpage>
<pub-id pub-id-type="pmid">22752870</pub-id>
</element-citation>
</ref>
<ref id="b133-ceg-10-091">
<label>133</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khor</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gardet</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Xavier</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Genetics and pathogenesis of inflammatory bowel disease</article-title>
<source/>Nature
          <year>2011</year>
<volume>474</volume>
<issue>7351</issue>
<fpage>307</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="pmid">21677747</pub-id>
</element-citation>
</ref>
<ref id="b134-ceg-10-091">
<label>134</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ek</surname>
<given-names>WE</given-names>
</name>
<name>
<surname>D’Amato</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Halfvarson</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The history of genetics in inflammatory bowel disease</article-title>
<source/>Ann Gastroenterol
          <year>2014</year>
<volume>27</volume>
<issue>4</issue>
<fpage>294</fpage>
<lpage>303</lpage>
<pub-id pub-id-type="pmid">25331623</pub-id>
</element-citation>
</ref>
<ref id="b135-ceg-10-091">
<label>135</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Economou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pappas</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>New global map of Crohn’s disease: genetic, environmental, and socioeconomic correlations</article-title>
<source/>Inflamm Bowel Dis
          <year>2008</year>
<volume>14</volume>
<issue>5</issue>
<fpage>709</fpage>
<lpage>720</lpage>
<pub-id pub-id-type="pmid">18095316</pub-id>
</element-citation>
</ref>
<ref id="b136-ceg-10-091">
<label>136</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swanson</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Burgess</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Keshavarzian</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare?</article-title>
<source/>Expert Rev Clin Immunol
          <year>2011</year>
<volume>7</volume>
<issue>1</issue>
<fpage>29</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="pmid">21162647</pub-id>
</element-citation>
</ref>
<ref id="b137-ceg-10-091">
<label>137</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ali</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Choe</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Awab</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wagener</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Orr</surname>
<given-names>WC</given-names>
</name>
</person-group>
<article-title>Sleep, immunity and inflammation in gastrointestinal disorders</article-title>
<source/>World J Gastroenterol
          <year>2013</year>
<volume>19</volume>
<issue>48</issue>
<fpage>9231</fpage>
<lpage>9239</lpage>
<pub-id pub-id-type="pmid">24409051</pub-id>
</element-citation>
</ref>
<ref id="b138-ceg-10-091">
<label>138</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kinnucan</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Sleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammation</article-title>
<source/>Gastroenterol Hepatol
          <year>2013</year>
<volume>9</volume>
<issue>11</issue>
<fpage>718</fpage>
<lpage>727</lpage>
</element-citation>
</ref>
<ref id="b139-ceg-10-091">
<label>139</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gamaldo</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Shaikh</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>McArthur</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>The sleep-immunity relationship</article-title>
<source/>Neurol Clin
          <year>2012</year>
<volume>30</volume>
<issue>4</issue>
<fpage>1313</fpage>
<lpage>1343</lpage>
<pub-id pub-id-type="pmid">23099140</pub-id>
</element-citation>
</ref>
<ref id="b140-ceg-10-091">
<label>140</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sookoian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gemma</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fernández Gianotti</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of rotating shift work on biomarkers of metabolic syndrome and inflammation</article-title>
<source/>J Intern Med
          <year>2007</year>
<volume>261</volume>
<issue>3</issue>
<fpage>285</fpage>
<lpage>292</lpage>
<pub-id pub-id-type="pmid">17305651</pub-id>
</element-citation>
</ref>
<ref id="b141-ceg-10-091">
<label>141</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ranjbaran</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Keefer</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Stepanski</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Farhadi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Keshavarzian</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The relevance of sleep abnormalities to chronic inflammatory conditions</article-title>
<source/>Inflamm Res
          <year>2007</year>
<volume>56</volume>
<issue>2</issue>
<fpage>51</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="pmid">17431741</pub-id>
</element-citation>
</ref>
<ref id="b142-ceg-10-091">
<label>142</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Cauter</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Spiegel</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tasali</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Leproult</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Metabolic consequences of sleep and sleep loss</article-title>
<source/>Sleep Med
          <year>2008</year>
<volume>9</volume>
<issue>Suppl 1</issue>
<fpage>S23</fpage>
<lpage>S28</lpage>
<pub-id pub-id-type="pmid">18929315</pub-id>
</element-citation>
</ref>
<ref id="b143-ceg-10-091">
<label>143</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Danese</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sans</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fiocchi</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Inflammatory bowel disease: the role of environmental factors</article-title>
<source/>Autoimmun Rev
          <year>2004</year>
<volume>3</volume>
<issue>5</issue>
<fpage>394</fpage>
<lpage>400</lpage>
<pub-id pub-id-type="pmid">15288007</pub-id>
</element-citation>
</ref>
<ref id="b144-ceg-10-091">
<label>144</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Molodecky</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Kaplan</surname>
<given-names>GG</given-names>
</name>
</person-group>
<article-title>Environmental risk factors for inflammatory bowel disease</article-title>
<source/>Gastroenterol Hepatol
          <year>2010</year>
<volume>6</volume>
<issue>5</issue>
<fpage>339</fpage>
<lpage>346</lpage>
</element-citation>
</ref>
<ref id="b145-ceg-10-091">
<label>145</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsuoka</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kanai</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>The gut microbiota and inflammatory bowel disease</article-title>
<source/>Semin Immunopathol
          <year>2015</year>
<volume>37</volume>
<fpage>47</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="pmid">25420450</pub-id>
</element-citation>
</ref>
<ref id="b146-ceg-10-091">
<label>146</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeGruttola</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Low</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mizoguchi</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Current understanding of dysbiosis in disease in human and animal models</article-title>
<source/>Inflamm Bowel Dis
          <year>2016</year>
<volume>22</volume>
<fpage>1137</fpage>
<lpage>1150</lpage>
<pub-id pub-id-type="pmid">27070911</pub-id>
</element-citation>
</ref>
<ref id="b147-ceg-10-091">
<label>147</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>XC</given-names>
</name>
<name>
<surname>Tickle</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Sokol</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment</article-title>
<source/>Genome Biol
          <year>2012</year>
<volume>13</volume>
<issue>9</issue>
<fpage>R79</fpage>
<pub-id pub-id-type="pmid">23013615</pub-id>
</element-citation>
</ref>
<ref id="b148-ceg-10-091">
<label>148</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dam</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Berg</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Farraye</surname>
<given-names>FA</given-names>
</name>
</person-group>
<article-title>Environmental influences on the onset and clinical course of Crohn’s disease—Part 1: an overview of external risk factors</article-title>
<source/>Gastroenterol Hepatol
          <year>2013</year>
<volume>9</volume>
<issue>11</issue>
<fpage>711</fpage>
<lpage>717</lpage>
</element-citation>
</ref>
<ref id="b149-ceg-10-091">
<label>149</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahid</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Minor</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Soto</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Hornung</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Galandiuk</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Smoking and inflammatory bowel disease: a meta-analysis</article-title>
<source/>Mayo Clin Proc
          <year>2006</year>
<volume>81</volume>
<fpage>1462</fpage>
<lpage>1471</lpage>
<pub-id pub-id-type="pmid">17120402</pub-id>
</element-citation>
</ref>
<ref id="b150-ceg-10-091">
<label>150</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higuchi</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Khalili</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Bousvaros</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>CS</given-names>
</name>
</person-group>
<article-title>A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women</article-title>
<source/>Am J Gastroenterol
          <year>2012</year>
<volume>107</volume>
<fpage>1399</fpage>
<lpage>1406</lpage>
<pub-id pub-id-type="pmid">22777340</pub-id>
</element-citation>
</ref>
<ref id="b151-ceg-10-091">
<label>151</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macfarlane</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bahrami</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Macfarlane</surname>
<given-names>GT</given-names>
</name>
</person-group>
<article-title>Mucosal biofilm communities in the human intestinal tract</article-title>
<source/>Adv Appl Microbiol
          <year>2011</year>
<volume>75</volume>
<fpage>111</fpage>
<lpage>143</lpage>
<pub-id pub-id-type="pmid">21807247</pub-id>
</element-citation>
</ref>
<ref id="b152-ceg-10-091">
<label>152</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macfarlane</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Steed</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Macfarlane</surname>
<given-names>GT</given-names>
</name>
</person-group>
<article-title>Intestinal bacteria and inflammatory bowel disease</article-title>
<source/>Crit Rev Clin Lab Sci
          <year>2009</year>
<volume>46</volume>
<issue>1</issue>
<fpage>25</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="pmid">19107650</pub-id>
</element-citation>
</ref>
<ref id="b153-ceg-10-091">
<label>153</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steed</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Macfarlane</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Blackett</surname>
<given-names>KL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical trial: the microbiological and immunological effects of symbiotic consumption – a randomized double-blind placebo-controlled study in active Crohn’s disease</article-title>
<source/>Aliment Pharmacol Ther
          <year>2010</year>
<volume>32</volume>
<issue>7</issue>
<fpage>872</fpage>
<lpage>883</lpage>
<pub-id pub-id-type="pmid">20735782</pub-id>
</element-citation>
</ref>
<ref id="b154-ceg-10-091">
<label>154</label>
<element-citation publication-type="webpage">
<person-group person-group-type="author">
<collab>Crohn’s and Colitis UK</collab>
</person-group>
<source/>Ulcerative Colitis [webpage on the Internet]
          <year>2016</year>
<comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://s3-eu-west-1.amazonaws.com/files.crohnsandcolitis.org.uk/Publications/ulcerative-colitis.pdf">http://s3-eu-west-1.amazonaws.com/files.crohnsandcolitis.org.uk/Publications/ulcerative-colitis.pdf</ext-link></comment>
<date-in-citation>Accessed August 31, 2016</date-in-citation>
</element-citation>
</ref>
<ref id="b155-ceg-10-091">
<label>155</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miele</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pascarella</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Giannetti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Quaglietta</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Baldassano</surname>
<given-names>RN</given-names>
</name>
</person-group>
<article-title>Effect of a probiotic preparation (VSL # 3) on induction and maintenance of remission in children with ulcerative colitis</article-title>
<source/>Am J Gastroenterol
          <year>2009</year>
<volume>104</volume>
<issue>2</issue>
<fpage>437</fpage>
<lpage>443</lpage>
<pub-id pub-id-type="pmid">19174792</pub-id>
</element-citation>
</ref>
<ref id="b156-ceg-10-091">
<label>156</label>
<element-citation publication-type="webpage">
<person-group person-group-type="author">
<collab>NHS</collab>
</person-group>
<source/>PrescQIPP. Review of probiotic treatment, including VSL#3® for ileoanal-pouchitis (DROP-List)
          <series>Bulletin 82</series>
<year>2014</year>
<comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://pad.res360.net/Content/Documents/PresQIPP-bulletin-82-probiotics.pdf">http://pad.res360.net/Content/Documents/PresQIPP-bulletin-82-probiotics.pdf</ext-link></comment>
<date-in-citation>Accessed February 27, 2017</date-in-citation>
</element-citation>
</ref>
<ref id="b157-ceg-10-091">
<label>157</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selinger</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cairns</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lockett</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sebastian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Haslam</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Probiotic VSL# 3 prevents antibiotic-associated diarrhea in a double-blind, randomized, placebo-controlled clinical trial</article-title>
<source/>J Hosp Infect
          <year>2013</year>
<volume>84</volume>
<issue>2</issue>
<fpage>159</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="pmid">23618760</pub-id>
</element-citation>
</ref>
<ref id="b158-ceg-10-091">
<label>158</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andrews</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Probiotics in luminal gastroenterology: the current state of play</article-title>
<source/>Intern Med J
          <year>2012</year>
<volume>42</volume>
<issue>12</issue>
<fpage>1287</fpage>
<lpage>1291</lpage>
<pub-id pub-id-type="pmid">23252997</pub-id>
</element-citation>
</ref>
<ref id="b159-ceg-10-091">
<label>159</label>
<element-citation publication-type="webpage">
<person-group person-group-type="author">
<collab>National Institute for Health and Clinical Excellence (NICE)</collab>
</person-group>
<source/>Irritable bowel syndrome in adults: diagnosis and management [webpage on the Internet]
          <year>2015</year>
<comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.nice.org.uk/Guidance/cg61">https://www.nice.org.uk/Guidance/cg61</ext-link></comment>
<date-in-citation>Accessed August 31, 2016</date-in-citation>
</element-citation>
</ref>
<ref id="b160-ceg-10-091">
<label>160</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vahedi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ansari</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mir-Nasseri</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Jafari</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Irritable bowel syndrome: a review article</article-title>
<source/>Middle East J Dig Dis
          <year>2010</year>
<volume>2</volume>
<issue>2</issue>
<fpage>66</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="pmid">25197516</pub-id>
</element-citation>
</ref>
<ref id="b161-ceg-10-091">
<label>161</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madden</surname>
<given-names>JAJ</given-names>
</name>
<name>
<surname>Hunter</surname>
<given-names>JO</given-names>
</name>
</person-group>
<article-title>A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics</article-title>
<source/>Bri J Nutr
          <year>2002</year>
<volume>88</volume>
<issue>Suppl 1</issue>
<fpage>67</fpage>
<lpage>72</lpage>
</element-citation>
</ref>
<ref id="b162-ceg-10-091">
<label>162</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gritz</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Bhandari</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>The human neonatal gut microbiome: a brief review</article-title>
<source/>Frontiers in Pediatr
          <year>2015</year>
<volume>3</volume>
<fpage>17</fpage>
</element-citation>
</ref>
<ref id="b163-ceg-10-091">
<label>163</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grönlund</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Lehtonen</surname>
<given-names>OP</given-names>
</name>
<name>
<surname>Eerola</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kero</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery</article-title>
<source/>J Pediat Gastroenterol Nutr
          <year>1999</year>
<volume>28</volume>
<issue>1</issue>
<fpage>19</fpage>
<lpage>25</lpage>
</element-citation>
</ref>
<ref id="b164-ceg-10-091">
<label>164</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pandey</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bavdekar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Patole</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Shouche</surname>
<given-names>YS</given-names>
</name>
</person-group>
<article-title>Comparative analysis of fecal microflora of healthy full-term Indian infants born with different methods of delivery (vaginal vs cesarean): Acinetobacter sp. prevalence in vaginally born infants</article-title>
<source/>J Biosci
          <year>2012</year>
<volume>37</volume>
<issue>6</issue>
<fpage>989</fpage>
<lpage>998</lpage>
<pub-id pub-id-type="pmid">23151789</pub-id>
</element-citation>
</ref>
<ref id="b165-ceg-10-091">
<label>165</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aagaard</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Antony</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Ganu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Petrosino</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Versalovic</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The placenta harbors a unique microbiome</article-title>
<source/>Sci Transl Med
          <year>2014</year>
<volume>6</volume>
<issue>237</issue>
<fpage>237ra65</fpage>
</element-citation>
</ref>
<ref id="b166-ceg-10-091">
<label>166</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adlerberth</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Wold</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>Establishment of the gut microbiota in Western infants</article-title>
<source/>Acta Paediatr
          <year>2009</year>
<volume>98</volume>
<fpage>229</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="pmid">19143664</pub-id>
</element-citation>
</ref>
<ref id="b167-ceg-10-091">
<label>167</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okada</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kuhn</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Feillet</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bach</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The “hygiene hypothesis” for autoimmune and allergic diseases: an update</article-title>
<source/>Clin Exp Immunol
          <year>2010</year>
<volume>160</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>9</lpage>
</element-citation>
</ref>
<ref id="b168-ceg-10-091">
<label>168</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Houghteling</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>WA</given-names>
</name>
</person-group>
<article-title>Why is initial bacterial colonization of the intestine important to the infant’s and child’s health?</article-title>
<source/>J Pediatr Gastroenterol Nutr
          <year>2015</year>
<volume>60</volume>
<issue>3</issue>
<fpage>294</fpage>
<lpage>307</lpage>
<pub-id pub-id-type="pmid">25313849</pub-id>
</element-citation>
</ref>
<ref id="b169-ceg-10-091">
<label>169</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guaraldi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Salvatori</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Effect of breast and formula feeding on gut microbiota shaping in newborns</article-title>
<source/>Front Cell Infect Microbiol
          <year>2012</year>
<volume>2</volume>
<fpage>94</fpage>
<pub-id pub-id-type="pmid">23087909</pub-id>
</element-citation>
</ref>
<ref id="b170-ceg-10-091">
<label>170</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marcobal</surname>
<given-names>A1</given-names>
</name>
<name>
<surname>Barboza</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Froehlich</surname>
<given-names>JW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Consumption of human milk oligosaccharides by gut-related microbes</article-title>
<source/>J Agric Food Chem
          <year>2010</year>
<volume>58</volume>
<issue>9</issue>
<fpage>5334</fpage>
<lpage>5340</lpage>
<pub-id pub-id-type="pmid">20394371</pub-id>
</element-citation>
</ref>
<ref id="b171-ceg-10-091">
<label>171</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ballard</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Morrow</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>Human milk composition: nutrients and bioactive factors</article-title>
<source/>Pediatr Clin North Am
          <year>2013</year>
<volume>60</volume>
<issue>1</issue>
<fpage>49</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">23178060</pub-id>
</element-citation>
</ref>
<ref id="b172-ceg-10-091">
<label>172</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Brand-Miller</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The role and potential of sialic acid in human nutrition</article-title>
<source/>Eur J Clin Nutr
          <year>2003</year>
<volume>57</volume>
<issue>11</issue>
<fpage>1351</fpage>
<lpage>1369</lpage>
<pub-id pub-id-type="pmid">14576748</pub-id>
</element-citation>
</ref>
<ref id="b173-ceg-10-091">
<label>173</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>ZT</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kling</surname>
<given-names>DE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota</article-title>
<source/>Glycobiology
          <year>2013</year>
<volume>23</volume>
<issue>2</issue>
<fpage>169</fpage>
<lpage>177</lpage>
<pub-id pub-id-type="pmid">23028202</pub-id>
</element-citation>
</ref>
<ref id="b174-ceg-10-091">
<label>174</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomez de Agüero</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ganal-Vonarburg</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Fuhrer</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The maternal microbiota drives early postnatal innate immune development</article-title>
<source/>Science
          <year>2016</year>
<volume>351</volume>
<issue>6279</issue>
<fpage>1296</fpage>
<lpage>1302</lpage>
<pub-id pub-id-type="pmid">26989247</pub-id>
</element-citation>
</ref>
<ref id="b175-ceg-10-091">
<label>175</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biagi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Candela</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fairweather-Tait</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Franceschi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Brigidi</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Ageing of the human metaorganism: the microbial counterpart</article-title>
<source/>Age
          <year>2012</year>
<volume>34</volume>
<issue>1</issue>
<fpage>247</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="pmid">21347607</pub-id>
</element-citation>
</ref>
<ref id="b176-ceg-10-091">
<label>176</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Odamaki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sugahara</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study</article-title>
<source/>BMC Microbiol
          <year>2016</year>
<volume>16</volume>
<fpage>90</fpage>
<pub-id pub-id-type="pmid">27220822</pub-id>
</element-citation>
</ref>
<ref id="b177-ceg-10-091">
<label>177</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Claesson</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Jeffery</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Conde</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiota composition correlates with diet and health in the elderly</article-title>
<source/>Nature
          <year>2012</year>
<volume>488</volume>
<issue>7410</issue>
<fpage>178</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="pmid">22797518</pub-id>
</element-citation>
</ref>
<ref id="b178-ceg-10-091">
<label>178</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hughes</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Microbiome: cultural differences</article-title>
<source/>Nature
          <year>2012</year>
<volume>492</volume>
<issue>7427</issue>
<fpage>S14</fpage>
<lpage>S15</lpage>
<pub-id pub-id-type="pmid">23222668</pub-id>
</element-citation>
</ref>
<ref id="b179-ceg-10-091">
<label>179</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biagi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nylund</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Candela</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians</article-title>
<source/>PLoS One
          <year>2010</year>
<volume>5</volume>
<issue>5</issue>
<fpage>e10667</fpage>
<pub-id pub-id-type="pmid">20498852</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>